jamjam的个人主页 - 老虎社区

jamjam

jamjam

暂无个人介绍

IP属地：未知

416关注

39粉丝

0主题

0勋章

2021-09-30

Like and commnet

Bed Bath & Beyond stock plunged 13.4% in premarket trading

2021-09-30

Like and comment

Bed Bath & Beyond stock plunged 13.4% in premarket trading

2021-09-27

$Naked Brand(NAKD)$$1

2021-09-24

Like and commnet

If Bitcoin Really Is Digital Gold, Then $500,000 Is the Next Stop

2021-10-02

Like and comment

Wells Fargo & Co. Stock Rises Friday, Outperforms Market

2021-10-02

Ok

Wells Fargo & Co. Stock Rises Friday, Outperforms Market

2021-10-02

$Palantir Technologies Inc.(PLTR)$gogogo

2021-09-26

$Cerebain Biotech Corp.(CBBT)$yes

2021-12-02

$Precipio, Inc.(PRPO)$Rebound will come!

2021-10-04

$Palantir Technologies Inc.(PLTR)$dammm

2021-09-29

$Alibaba(BABA)$buy when low

2021-09-27

$Cerebain Biotech Corp.(CBBT)$yess

2021-09-27

$Naked Brand(NAKD)$whoooooooop

2021-09-30

All in

4 Stocks Expected to Increase Sales 25,750% to 2,970,000% in 5 Years

2021-09-30

$Palantir Technologies Inc.(PLTR)$well

2021-09-29

$Precipio, Inc.(PRPO)$zzzzzz

2021-09-28

$Precipio, Inc.(PRPO)$omg

2021-09-27

$Cerebain Biotech Corp.(CBBT)$kkkkk

2021-09-26

$Cerebain Biotech Corp.(CBBT)$haha

2021-09-26

$Cerebain Biotech Corp.(CBBT)$yes

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3559204036277229,"uuid":"3559204036277229","gmtCreate":1596110166939,"gmtModify":1704447526044,"name":"jamjam","pinyin":"jamjam","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":39,"headSize":416,"tweetSize":518,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.85%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.04.27","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.26%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":603806655,"gmtCreate":1638388806283,"gmtModify":1638388807079,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PRPO\">$Precipio, Inc.(PRPO)$</a>Rebound will come!","listText":"<a href=\"https://laohu8.com/S/PRPO\">$Precipio, Inc.(PRPO)$</a>Rebound will come!","text":"$Precipio, Inc.(PRPO)$Rebound will come!","images":[{"img":"https://static.tigerbbs.com/ef3e2f133c59107eb0b3191ab6335623","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603806655","isVote":1,"tweetType":1,"viewCount":631,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":820363428,"gmtCreate":1633354412369,"gmtModify":1633354474632,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>dammm","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>dammm","text":"$Palantir Technologies Inc.(PLTR)$dammm","images":[{"img":"https://static.tigerbbs.com/2f80ab815eb8dc567b6b02b30422b1f2","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820363428","isVote":1,"tweetType":1,"viewCount":664,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":864704246,"gmtCreate":1633144661009,"gmtModify":1633144661758,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like and comment&nbsp;","listText":"Like and comment&nbsp;","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/864704246","repostId":"2172969568","repostType":4,"repost":{"id":"2172969568","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1633123800,"share":"https://www.laohu8.com/m/news/2172969568?lang=&edition=full","pubTime":"2021-10-02 05:30","market":"hk","language":"en","title":"Wells Fargo & Co. Stock Rises Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2172969568","media":"Dow Jones","summary":"Shares of Wells Fargo & Co. $(WFC)$ advanced 1.31% to $47.02 Friday, on what proved to be an all-aro","content":"<p>Shares of Wells Fargo &amp; Co. <a href=\"https://laohu8.com/S/WFC\">$(WFC)$</a> advanced 1.31% to $47.02 Friday, on what proved to be an all-around great trading session for the stock market, with the S&amp;P 500 Index rising 1.15% to 4,357.04 and the Dow Jones Industrial Average rising 1.43% to 34,326.46. Wells Fargo &amp; Co. closed $4.39 short of its 52-week high ($51.41), which the company reached on August 13th.</p>\n<p>The stock underperformed when compared to some of its competitors Friday, as JPMorgan Chase &amp; Co. <a href=\"https://laohu8.com/S/JPM\">$(JPM)$</a> rose 2.10% to $167.13, $Bank of America Corp(BAC-N)$. <a href=\"https://laohu8.com/S/BAC\">$(BAC)$</a> rose 1.48% to $43.08, and $Citigroup Inc(C-N)$. <a href=\"https://laohu8.com/S/C\">$(C)$</a> rose 1.42% to $71.18. Trading volume (18.0 M) remained 8.8 million below its 50-day average volume of 26.8 M.</p>\n<p>Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2021.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wells Fargo & Co. Stock Rises Friday, Outperforms Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWells Fargo & Co. Stock Rises Friday, Outperforms Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-10-02 05:30</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Wells Fargo &amp; Co. <a href=\"https://laohu8.com/S/WFC\">$(WFC)$</a> advanced 1.31% to $47.02 Friday, on what proved to be an all-around great trading session for the stock market, with the S&amp;P 500 Index rising 1.15% to 4,357.04 and the Dow Jones Industrial Average rising 1.43% to 34,326.46. Wells Fargo &amp; Co. closed $4.39 short of its 52-week high ($51.41), which the company reached on August 13th.</p>\n<p>The stock underperformed when compared to some of its competitors Friday, as JPMorgan Chase &amp; Co. <a href=\"https://laohu8.com/S/JPM\">$(JPM)$</a> rose 2.10% to $167.13, $Bank of America Corp(BAC-N)$. <a href=\"https://laohu8.com/S/BAC\">$(BAC)$</a> rose 1.48% to $43.08, and $Citigroup Inc(C-N)$. <a href=\"https://laohu8.com/S/C\">$(C)$</a> rose 1.42% to $71.18. Trading volume (18.0 M) remained 8.8 million below its 50-day average volume of 26.8 M.</p>\n<p>Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2021.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WFC":"富国银行"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172969568","content_text":"Shares of Wells Fargo & Co. $(WFC)$ advanced 1.31% to $47.02 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.15% to 4,357.04 and the Dow Jones Industrial Average rising 1.43% to 34,326.46. Wells Fargo & Co. closed $4.39 short of its 52-week high ($51.41), which the company reached on August 13th.\nThe stock underperformed when compared to some of its competitors Friday, as JPMorgan Chase & Co. $(JPM)$ rose 2.10% to $167.13, $Bank of America Corp(BAC-N)$. $(BAC)$ rose 1.48% to $43.08, and $Citigroup Inc(C-N)$. $(C)$ rose 1.42% to $71.18. Trading volume (18.0 M) remained 8.8 million below its 50-day average volume of 26.8 M.\nData source: Dow Jones Market Data, FactSet. Data compiled October 1, 2021.","news_type":1},"isVote":1,"tweetType":1,"viewCount":311,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864704819,"gmtCreate":1633144640166,"gmtModify":1633144640925,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/864704819","repostId":"2172969568","repostType":4,"repost":{"id":"2172969568","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1633123800,"share":"https://www.laohu8.com/m/news/2172969568?lang=&edition=full","pubTime":"2021-10-02 05:30","market":"hk","language":"en","title":"Wells Fargo & Co. Stock Rises Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2172969568","media":"Dow Jones","summary":"Shares of Wells Fargo & Co. $(WFC)$ advanced 1.31% to $47.02 Friday, on what proved to be an all-aro","content":"<p>Shares of Wells Fargo &amp; Co. <a href=\"https://laohu8.com/S/WFC\">$(WFC)$</a> advanced 1.31% to $47.02 Friday, on what proved to be an all-around great trading session for the stock market, with the S&amp;P 500 Index rising 1.15% to 4,357.04 and the Dow Jones Industrial Average rising 1.43% to 34,326.46. Wells Fargo &amp; Co. closed $4.39 short of its 52-week high ($51.41), which the company reached on August 13th.</p>\n<p>The stock underperformed when compared to some of its competitors Friday, as JPMorgan Chase &amp; Co. <a href=\"https://laohu8.com/S/JPM\">$(JPM)$</a> rose 2.10% to $167.13, $Bank of America Corp(BAC-N)$. <a href=\"https://laohu8.com/S/BAC\">$(BAC)$</a> rose 1.48% to $43.08, and $Citigroup Inc(C-N)$. <a href=\"https://laohu8.com/S/C\">$(C)$</a> rose 1.42% to $71.18. Trading volume (18.0 M) remained 8.8 million below its 50-day average volume of 26.8 M.</p>\n<p>Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2021.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wells Fargo & Co. Stock Rises Friday, Outperforms Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWells Fargo & Co. Stock Rises Friday, Outperforms Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-10-02 05:30</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Wells Fargo &amp; Co. <a href=\"https://laohu8.com/S/WFC\">$(WFC)$</a> advanced 1.31% to $47.02 Friday, on what proved to be an all-around great trading session for the stock market, with the S&amp;P 500 Index rising 1.15% to 4,357.04 and the Dow Jones Industrial Average rising 1.43% to 34,326.46. Wells Fargo &amp; Co. closed $4.39 short of its 52-week high ($51.41), which the company reached on August 13th.</p>\n<p>The stock underperformed when compared to some of its competitors Friday, as JPMorgan Chase &amp; Co. <a href=\"https://laohu8.com/S/JPM\">$(JPM)$</a> rose 2.10% to $167.13, $Bank of America Corp(BAC-N)$. <a href=\"https://laohu8.com/S/BAC\">$(BAC)$</a> rose 1.48% to $43.08, and $Citigroup Inc(C-N)$. <a href=\"https://laohu8.com/S/C\">$(C)$</a> rose 1.42% to $71.18. Trading volume (18.0 M) remained 8.8 million below its 50-day average volume of 26.8 M.</p>\n<p>Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2021.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WFC":"富国银行"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172969568","content_text":"Shares of Wells Fargo & Co. $(WFC)$ advanced 1.31% to $47.02 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.15% to 4,357.04 and the Dow Jones Industrial Average rising 1.43% to 34,326.46. Wells Fargo & Co. closed $4.39 short of its 52-week high ($51.41), which the company reached on August 13th.\nThe stock underperformed when compared to some of its competitors Friday, as JPMorgan Chase & Co. $(JPM)$ rose 2.10% to $167.13, $Bank of America Corp(BAC-N)$. $(BAC)$ rose 1.48% to $43.08, and $Citigroup Inc(C-N)$. $(C)$ rose 1.42% to $71.18. Trading volume (18.0 M) remained 8.8 million below its 50-day average volume of 26.8 M.\nData source: Dow Jones Market Data, FactSet. Data compiled October 1, 2021.","news_type":1},"isVote":1,"tweetType":1,"viewCount":792,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864704948,"gmtCreate":1633144611026,"gmtModify":1633144611840,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>gogogo","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>gogogo","text":"$Palantir Technologies Inc.(PLTR)$gogogo","images":[{"img":"https://static.tigerbbs.com/0bc656080ec822fccf7491af16964d53","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864704948","isVote":1,"tweetType":1,"viewCount":633,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":865523533,"gmtCreate":1633003828765,"gmtModify":1633007324308,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"APPLE products seems to be getting boring. Maybe something like apple power plug. Expand more into xiaomi lifestyle products seems to be the way out.","listText":"APPLE products seems to be getting boring. Maybe something like apple power plug. Expand more into xiaomi lifestyle products seems to be the way out.","text":"APPLE products seems to be getting boring. Maybe something like apple power plug. Expand more into xiaomi lifestyle products seems to be the way out.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865523533","repostId":"1113114898","repostType":4,"repost":{"id":"1113114898","pubTimestamp":1633001805,"share":"https://www.laohu8.com/m/news/1113114898?lang=&edition=full","pubTime":"2021-09-30 19:36","market":"us","language":"en","title":"Apple: A Big Dilemma","url":"https://stock-news.laohu8.com/highlight/detail?id=1113114898","media":"Seeking Alpha","summary":"In a report by Loup Ventures, it estimated that Apple Pay is used by over half a billion users.Another note by Juniper Research predicts Apple Pay transactions hitting $686 billion by 2024.The future trajectory of Apple Pay can have a domino effect on other services which increases its importance for the stock.Apple  has been making a significant effort in improving the traction of its payments system. Loup Ventures has estimated that Apple Pay is now used by over half of iPhone users or 507 mil","content":"<p><b>Summary</b></p>\n<ul>\n <li>In a report by Loup Ventures, it estimated that Apple Pay is used by over half a billion users.</li>\n <li>Another note by Juniper Research predicts Apple Pay transactions hitting $686 billion by 2024.</li>\n <li>However, Apple faces a number of headwinds due to growing competitive climate, antitrust and inherent limitation of its ecosystem.</li>\n <li>Facebook, Amazon, Google and other big tech players are making a strong play in gaining market share in this highly lucrative business segment.</li>\n <li>The future trajectory of Apple Pay can have a domino effect on other services which increases its importance for the stock.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bdd5b8fd99a0523d96bf052afd8c1b37\" tg-width=\"1536\" tg-height=\"988\" width=\"100%\" height=\"auto\"><span>Nikada/iStock Unreleased via Getty Images</span></p>\n<p>Apple (AAPL) has been making a significant effort in improving the traction of its payments system. Loup Ventures&nbsp;has estimated&nbsp;that Apple Pay is now used by over half of iPhone users or 507 million. This represents 15% growth in Apple Pay users from the year-ago period. Another study by Juniper Research has estimated that Apple Pay transactions&nbsp;could hit&nbsp;$686 billion by 2024.</p>\n<p>These are good numbers for Apple but the company is also facing challenges on several fronts. It has a minuscule market share in China and is not even present in India. It is facing antitrust regulations in Europe which can limit the growth potential. Even in the domestic US market, other competitors are ramping up their efforts to gain a good chunk of digital payments. Apple does not have the retail ecosystem of Amazon (AMZN) and Alibaba (BABA), nor does it have a social media empire like Facebook (FB) and Tencent (OTCPK:TCEHY). This can limit the attraction of Apple Pay in several markets as this segment reaches maturity.</p>\n<p><b>Potential of payments services</b></p>\n<p>Loup Ventures has been making an annual study on the changing dynamics in the payments ecosystem for the past few years. Its first report in 2016 estimated that Apple Pay was used by only 67 million users which was 9% of the total iPhone installed base at that time. Since then, Apple Pay has come a long way. In the recent report, Apple Pay is estimated to have a whopping 507 million active users which is equal to 51% of the total iPhone installed base.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7da83d2ee0a94f22948bad15e574d818\" tg-width=\"758\" tg-height=\"312\" width=\"100%\" height=\"auto\"><span>Source: Loup Ventures</span></p>\n<p>Juniper Research has also estimated that Apple Pay would complete transactions worth $686 billion by 2024. When looking at Apple’s charges, this transaction scale could yield over a billion in revenue which would probably be a very high margin.</p>\n<p>Another big advantage for Apple is that it further strengthens the ecosystem of hardware and services. This will further increase customer loyalty and also promote new products and services launched by Apple.</p>\n<p><b>Challenges faced by Apple Pay</b></p>\n<p>Despite the high iPhone user base and millions of customers using Apple Pay, the company will need to surmount some very high barriers to corner a big market share in this industry. The core issue with Apple is that it does not have a retail or social media platform. This was the main reason behind the poor performance of Apple Pay in China. Most of the payments segment in China is divided between Alibaba and Tencent.</p>\n<p>Alibaba has been able to leverage its massive retail ecosystem to lure more customers to its Alipay platform and provide more financial services. Similarly, Tencent has been able to leverage its massive social media ecosystem to gain customers for WeChat Pay. As both these giants fought over payments market share, Apple Pay ended up becoming a fringe player in China. Even Harvard Business Review&nbsp;mentioned the huge obstacles&nbsp;faced by Apple Pay in replicating the success of Alipay in the US.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/147af64bc9ea22c57dcf284cf922d3ab\" tg-width=\"640\" tg-height=\"448\" width=\"100%\" height=\"auto\"><span>Figure: Adoption of Apple Pay for transactions. Source: Pymnts</span></p>\n<p>A recent report by Pymnts shows Apple's dilemma. While the devices capable of supporting Apple Pay have increased massively, the actual share of transactions with Apple Pay is still quite low. Higher acceptance by merchants has also not been a big help for Apple. The main issue again is the preference of customers to continue using their cards within the domestic US market.</p>\n<p>It should also be noted that the Chinese financial system and US financial system are very different. Lack of credit card penetration helped Alibaba and Tencent build a valuable payments platform in China. However, this is not the case in the US where card payments are available easily.</p>\n<p>Another important market where Apple lags is India. This region has significant similarities with China due to low card penetration. Hence, there has been a rapid growth in digital payments. Some of the main players in this region are Paytm (backed by SoftBank(OTCPK:SFTBY)), Amazon Pay, and Google Pay. Recently, Facebook also received regulatory permission to expand its payments option within WhatsApp which is used by over 400 million in this region. On the other hand, Apple has not even launched its payments option. It is likely that this region could see a maturity similar to China within the next few quarters. At this point, it would be impossible for Apple to gain market share from established players.</p>\n<p>Apple also faces obstacles in the lucrative European market where regulators are looking at antitrust options for Apple Pay. If Apple is limited in its growth in the European market, it will only have a decent presence in the domestic US market which should limit the growth runway in the future.</p>\n<p><b>A domino effect</b></p>\n<p>Apple Pay can be a very profitable segment on its own. However, it will have a much bigger impact on other products and services offered by Apple. For example, widespread use of Apple Pay will also help increase the sales of wearables like watches from which customers can make payments.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2a7a020d7359f75124d44eb75b765787\" tg-width=\"625\" tg-height=\"413\" width=\"100%\" height=\"auto\"><span>Source: Loup Ventures</span></p>\n<p>Apple has offered discounts to encourage more transactions. The&nbsp;company offered&nbsp;four months of free coffee at Panera Bread for customers using Apple Pay at checkout. It&nbsp;launched&nbsp;a 20% discount onGrubHubwhen customers make purchases of $10 or more and pay through Apple Pay. This is a similar strategy to Alipay and WeChat Pay in China where these companies offered massive discounts to attract customers in making smaller transactions on their platform.</p>\n<p>It will be important to note the success of these initiatives over the next few quarters. If Apple is able to expand its market share with the digital payments segment in the US it could help improve the bullishness towards Apple’s services. However, the company will be facing significant challenges from powerful tech giants. It is unlikely that we will see a similar trajectory for Apple Pay in the US similar to Alipay in China due to differences in the financial ecosystem. Apple could also face a major headwind in the next few years in the payments industry due to its lack of a strong retail or social media platform.</p>\n<p>Investors should closely look at the future numbers reported for Apple Pay as it will have a big impact on the growth potential of several products and services offered by the company.</p>\n<p><b>Investor Takeaway</b></p>\n<p>Apple has been making some progress in the payments industry with a higher active user base and more transactions on Apple Pay. However, it will likely have a very low market share in important international regions like Europe, China, India, and others. Even in the domestic US market, Apple will be competing against big giants like Amazon who can invest significant resources in increasing their own customer base.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple: A Big Dilemma</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple: A Big Dilemma\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-30 19:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4457628-apple-stock-big-dilemma><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nIn a report by Loup Ventures, it estimated that Apple Pay is used by over half a billion users.\nAnother note by Juniper Research predicts Apple Pay transactions hitting $686 billion by 2024.\n...</p>\n\n<a href=\"https://seekingalpha.com/article/4457628-apple-stock-big-dilemma\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://seekingalpha.com/article/4457628-apple-stock-big-dilemma","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113114898","content_text":"Summary\n\nIn a report by Loup Ventures, it estimated that Apple Pay is used by over half a billion users.\nAnother note by Juniper Research predicts Apple Pay transactions hitting $686 billion by 2024.\nHowever, Apple faces a number of headwinds due to growing competitive climate, antitrust and inherent limitation of its ecosystem.\nFacebook, Amazon, Google and other big tech players are making a strong play in gaining market share in this highly lucrative business segment.\nThe future trajectory of Apple Pay can have a domino effect on other services which increases its importance for the stock.\n\nNikada/iStock Unreleased via Getty Images\nApple (AAPL) has been making a significant effort in improving the traction of its payments system. Loup Ventures has estimated that Apple Pay is now used by over half of iPhone users or 507 million. This represents 15% growth in Apple Pay users from the year-ago period. Another study by Juniper Research has estimated that Apple Pay transactions could hit $686 billion by 2024.\nThese are good numbers for Apple but the company is also facing challenges on several fronts. It has a minuscule market share in China and is not even present in India. It is facing antitrust regulations in Europe which can limit the growth potential. Even in the domestic US market, other competitors are ramping up their efforts to gain a good chunk of digital payments. Apple does not have the retail ecosystem of Amazon (AMZN) and Alibaba (BABA), nor does it have a social media empire like Facebook (FB) and Tencent (OTCPK:TCEHY). This can limit the attraction of Apple Pay in several markets as this segment reaches maturity.\nPotential of payments services\nLoup Ventures has been making an annual study on the changing dynamics in the payments ecosystem for the past few years. Its first report in 2016 estimated that Apple Pay was used by only 67 million users which was 9% of the total iPhone installed base at that time. Since then, Apple Pay has come a long way. In the recent report, Apple Pay is estimated to have a whopping 507 million active users which is equal to 51% of the total iPhone installed base.\nSource: Loup Ventures\nJuniper Research has also estimated that Apple Pay would complete transactions worth $686 billion by 2024. When looking at Apple’s charges, this transaction scale could yield over a billion in revenue which would probably be a very high margin.\nAnother big advantage for Apple is that it further strengthens the ecosystem of hardware and services. This will further increase customer loyalty and also promote new products and services launched by Apple.\nChallenges faced by Apple Pay\nDespite the high iPhone user base and millions of customers using Apple Pay, the company will need to surmount some very high barriers to corner a big market share in this industry. The core issue with Apple is that it does not have a retail or social media platform. This was the main reason behind the poor performance of Apple Pay in China. Most of the payments segment in China is divided between Alibaba and Tencent.\nAlibaba has been able to leverage its massive retail ecosystem to lure more customers to its Alipay platform and provide more financial services. Similarly, Tencent has been able to leverage its massive social media ecosystem to gain customers for WeChat Pay. As both these giants fought over payments market share, Apple Pay ended up becoming a fringe player in China. Even Harvard Business Review mentioned the huge obstacles faced by Apple Pay in replicating the success of Alipay in the US.\nFigure: Adoption of Apple Pay for transactions. Source: Pymnts\nA recent report by Pymnts shows Apple's dilemma. While the devices capable of supporting Apple Pay have increased massively, the actual share of transactions with Apple Pay is still quite low. Higher acceptance by merchants has also not been a big help for Apple. The main issue again is the preference of customers to continue using their cards within the domestic US market.\nIt should also be noted that the Chinese financial system and US financial system are very different. Lack of credit card penetration helped Alibaba and Tencent build a valuable payments platform in China. However, this is not the case in the US where card payments are available easily.\nAnother important market where Apple lags is India. This region has significant similarities with China due to low card penetration. Hence, there has been a rapid growth in digital payments. Some of the main players in this region are Paytm (backed by SoftBank(OTCPK:SFTBY)), Amazon Pay, and Google Pay. Recently, Facebook also received regulatory permission to expand its payments option within WhatsApp which is used by over 400 million in this region. On the other hand, Apple has not even launched its payments option. It is likely that this region could see a maturity similar to China within the next few quarters. At this point, it would be impossible for Apple to gain market share from established players.\nApple also faces obstacles in the lucrative European market where regulators are looking at antitrust options for Apple Pay. If Apple is limited in its growth in the European market, it will only have a decent presence in the domestic US market which should limit the growth runway in the future.\nA domino effect\nApple Pay can be a very profitable segment on its own. However, it will have a much bigger impact on other products and services offered by Apple. For example, widespread use of Apple Pay will also help increase the sales of wearables like watches from which customers can make payments.\nSource: Loup Ventures\nApple has offered discounts to encourage more transactions. The company offered four months of free coffee at Panera Bread for customers using Apple Pay at checkout. It launched a 20% discount onGrubHubwhen customers make purchases of $10 or more and pay through Apple Pay. This is a similar strategy to Alipay and WeChat Pay in China where these companies offered massive discounts to attract customers in making smaller transactions on their platform.\nIt will be important to note the success of these initiatives over the next few quarters. If Apple is able to expand its market share with the digital payments segment in the US it could help improve the bullishness towards Apple’s services. However, the company will be facing significant challenges from powerful tech giants. It is unlikely that we will see a similar trajectory for Apple Pay in the US similar to Alipay in China due to differences in the financial ecosystem. Apple could also face a major headwind in the next few years in the payments industry due to its lack of a strong retail or social media platform.\nInvestors should closely look at the future numbers reported for Apple Pay as it will have a big impact on the growth potential of several products and services offered by the company.\nInvestor Takeaway\nApple has been making some progress in the payments industry with a higher active user base and more transactions on Apple Pay. However, it will likely have a very low market share in important international regions like Europe, China, India, and others. Even in the domestic US market, Apple will be competing against big giants like Amazon who can invest significant resources in increasing their own customer base.","news_type":1},"isVote":1,"tweetType":1,"viewCount":514,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865529303,"gmtCreate":1633003714272,"gmtModify":1633003715062,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"All in","listText":"All in","text":"All in","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865529303","repostId":"2171937752","repostType":4,"repost":{"id":"2171937752","pubTimestamp":1633002256,"share":"https://www.laohu8.com/m/news/2171937752?lang=&edition=full","pubTime":"2021-09-30 19:44","market":"us","language":"en","title":"4 Stocks Expected to Increase Sales 25,750% to 2,970,000% in 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2171937752","media":"Motley Fool","summary":"These companies could deliver jaw-dropping revenue growth through mid-decade.","content":"<p>High-growth stocks have dominated Wall Street for more than a decade -- and with good reason. Historically low lending rates and an accommodative monetary policy have paved the way for fast-paced companies to borrow at attractive rates.</p>\n<p>But for some companies, sales growth is about to kick into high gear. When you're building a business from the ground up, going from practically nothing in sales to hundreds of millions or billions of dollars in revenue in just a couple of years can be a jaw-dropping experience.</p>\n<p>The following four companies are expected to do just that. According to Wall Street's consensus estimates, these four stocks are forecast to increase sales by 25,750% to as much as 2,970,000% (that's nearly 3 million percent) over the next five years.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ee55796575e48ba3143c099af095e386\" tg-width=\"700\" tg-height=\"535\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Vaxart: 25,752% implied sales growth by 2025</h2>\n<p>A clinical-stage biotech stock angling for its first approved therapy is a perfect example of a business that could grow from a relatively small amount of non-recurring revenue to a considerably larger sum of recurring sales. Drug-developer <b>Vaxart</b> (NASDAQ:VXRT) is expected to increase its annual sales from the $4.05 million reported in 2020 to a consensus estimate of $1.047 billion by mid-decade. That's an increase of about 25,750%, if Wall Street's numbers prove accurate.</p>\n<p>Vaxart's future is pinned to the success of its VAAST platform. \"VAAST\" stands for Vector-Adjuvant-Antigen Standardized Technology and encompasses the company's attempts to develop proprietary oral vaccines. Whereas standard vaccines administered in a shot can activate systemic immunity, oral-vaccine tablets would be designed to activate systemic and mucosal immunity in the intestines, lungs, nose, and mouth. In other words, this dual-action approach could carry better immunity against potentially deadly viruses.</p>\n<p>The oral vaccine that's arguably received the most attention for Vaxart is VXA-CoV2-1, an early-stage tablet designed to combat the coronavirus disease 2019 (COVID-19). In May, Vaxart announced that its phase 1 study of VXA-CoV2-1 led to clear immune response in participants, although high levels of neutralizing antibodies weren't present. Traditional shot-in-the-arm vaccines have led to high levels of neutralizing antibodies in clinical trials.</p>\n<p>But Vaxart's work isn't close to being finished. In early August, it received the go-ahead from the U.S. Food and Drug Administration (FDA) to commence an oral-tablet study for a very specific protein to combat COVID-19. It could be some time before investors know if oral vaccines are a viable solution, but the convenience factor certainly makes this trial worth watching.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/650d01a926fded89c361069c76a528f5\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>CRISPR Technologies: 191,416% implied sales growth by 2025</h2>\n<p>Did I mention that clinical-stage biotech stocks are a great source of jaw-dropping growth over the next decade? <b>CRISPR Therapeutics</b> (NASDAQ:CRSP), a company leaning on gene-editing technology to precisely alter genomic DNA and tackle hard-to-treat diseases, is expected to see sales climb from $719,000 in 2020 to a consensus of $1.377 billion by 2025. That's an improvement of more than 191,000% in five years.</p>\n<p>Arguably the biggest positive for CRISPR is that it's working with <b>Vertex Pharmaceuticals</b> (NASDAQ:VRTX) in the development of CTX001 for the treatment of transfusion-dependent beta thalassemia (TDT) and sickle cell disease (SCD). Vertex has a storied history of developing novel therapies for hard-to-treat illnesses, such as cystic fibrosis.</p>\n<p>It also doesn't hurt that Vertex's deep pockets are helping to lift CRISPR's bank account. Following a $900 million collaboration payment in the second quarter, CRISPR was sitting on nearly $2.6 billion in cash, cash equivalents, and marketable securities. That's plenty of capital to fund its ongoing clinical studies.</p>\n<p>Initial trial data for CTX001 has also been encouraging. At the European Hematology Association's annual meeting in June, the company announced that all 15 patients with TDT were transfusion-free after follow-ups of at least three months. TDT patients can require weekly transfusions, depending on the severity of their illnesses. Management believes regulatory filings, assuming all goes well in clinical studies, could come by or before mid-2023.</p>\n<p>While CRISPR Technologies is far from the only company looking to tackle TDT and SCD, it's among the best funded and has Vertex in its corner. That gives it a better-than-average chance of success, at least in my book.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a38605bee8e62f3e8aa414fa24278e7e\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Ocugen: 604,551% implied sales growth by 2025</h2>\n<p>Yet another clinical-stage biotech company expected to see sales go from virtually zero to a big number with a lot of zeroes is <b>Ocugen</b> (NASDAQ:OCGN). After the company reported $43,000 in sales last year, Wall Street's consensus has it generating $260 million in full-year sales by 2025. We're talking about a nearly 605,000% sales increase in five years.</p>\n<p>Not to sound like a broken record, but a COVID-19 vaccine is Ocugen's potential catalyst. The company has partnered with India's Bharat Biotech for the commercialization of Covaxin. A phase 3 trial of 25,800 adults aged 18 and up in India demonstrated a vaccine efficacy of 77.8% for symptomatic infections, 63.6% against asymptomatic infections, and most importantly was 93.4% effective against severe COVID-19 disease. The July-reported data from Bharat also showed a 65.2% efficacy against the delta variant.</p>\n<p>With so many people left to be vaccinated, this probably sounds like a slam-dunk for some form of emergency authorization use in developed or emerging markets. However, there's a big problem for Ocugen: It only has co-commercialization rights for Covaxin in the U.S. and Canada. The U.S. has ordered more-than-enough vaccines to inoculate all eligible Americans, and likely has doses in reserve should booster shots become necessary. The same could be said for Canada, which invested heavily in vaccine purchases.</p>\n<p>While there's no such thing as having too many vaccine options during a pandemic, Covaxin's initial efficacy doesn't pop quite like the vaccines from <b>Moderna</b>, <b>Pfizer</b>/<b>BioNTech</b>, or even <b>Novavax</b>, which looks to be nearing its own emergency use authorization in the United States. Suffice it to say, Ocugen's sales forecast may prove unattainable.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/deae33b8912cffd8d0ba896164abff66\" tg-width=\"700\" tg-height=\"378\" width=\"100%\" height=\"auto\"><span>A rendering of the all-electric Nikola Tre semi. Image source: Nikola.</span></p>\n<h2>Nikola: 2,970,426% implied sales growth by 2025</h2>\n<p>However, the crème de la crème of growth opportunities, at least pertaining to this list, is electric vehicle (EV) manufacturer <b>Nikola</b> (NASDAQ:NKLA). The expectation is that we'll see Nikola's sales catapult from a reported $95,000 in 2020 to a consensus of $2.822 billion by 2025. This equates to almost a 3 million percent jump in annual revenue.</p>\n<p>The growth opportunity for EVs is pretty straightforward. With developed countries like the U.S. tackling climate change head-on, replacing fossil-fuel-burning vehicles with alternative-energy vehicles is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the easiest ways to make a difference. It's going to take decades for consumers and businesses to make this shift, which leaves plenty of room for multiple EV manufacturers to thrive.</p>\n<p>The issue for Nikola is that it's dealing with a public relations mess. Last year, short-side firm Hindenburg Research released a report that alleged Nikola was a fraud. Even though an independent review found that many of Hindenburg's allegations weren't true, it was discovered that founder Trevor Milton's statements regarding pre-sells weren't accurate.</p>\n<p>Despite stepping down last year, Milton was indicted by the U.S. Department of Justice on three charges of misleading investors. Ultimately, Nikola will have to overcome a breach of trust to sell its vehicles, and it likely will need a lot more cash than it has now to build up its production. Personally, I'm skeptical the company will reach this lofty sales consensus by mid-decade.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Stocks Expected to Increase Sales 25,750% to 2,970,000% in 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Stocks Expected to Increase Sales 25,750% to 2,970,000% in 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-30 19:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/30/4-stocks-increase-sales-25750-to-2970000-5-years/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>High-growth stocks have dominated Wall Street for more than a decade -- and with good reason. Historically low lending rates and an accommodative monetary policy have paved the way for fast-paced ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/30/4-stocks-increase-sales-25750-to-2970000-5-years/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NKLA":"Nikola Corporation","VXRT":"Vaxart, Inc","CRSP":"CRISPR Therapeutics AG","OCGN":"Ocugen"},"source_url":"https://www.fool.com/investing/2021/09/30/4-stocks-increase-sales-25750-to-2970000-5-years/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2171937752","content_text":"High-growth stocks have dominated Wall Street for more than a decade -- and with good reason. Historically low lending rates and an accommodative monetary policy have paved the way for fast-paced companies to borrow at attractive rates.\nBut for some companies, sales growth is about to kick into high gear. When you're building a business from the ground up, going from practically nothing in sales to hundreds of millions or billions of dollars in revenue in just a couple of years can be a jaw-dropping experience.\nThe following four companies are expected to do just that. According to Wall Street's consensus estimates, these four stocks are forecast to increase sales by 25,750% to as much as 2,970,000% (that's nearly 3 million percent) over the next five years.\nImage source: Getty Images.\nVaxart: 25,752% implied sales growth by 2025\nA clinical-stage biotech stock angling for its first approved therapy is a perfect example of a business that could grow from a relatively small amount of non-recurring revenue to a considerably larger sum of recurring sales. Drug-developer Vaxart (NASDAQ:VXRT) is expected to increase its annual sales from the $4.05 million reported in 2020 to a consensus estimate of $1.047 billion by mid-decade. That's an increase of about 25,750%, if Wall Street's numbers prove accurate.\nVaxart's future is pinned to the success of its VAAST platform. \"VAAST\" stands for Vector-Adjuvant-Antigen Standardized Technology and encompasses the company's attempts to develop proprietary oral vaccines. Whereas standard vaccines administered in a shot can activate systemic immunity, oral-vaccine tablets would be designed to activate systemic and mucosal immunity in the intestines, lungs, nose, and mouth. In other words, this dual-action approach could carry better immunity against potentially deadly viruses.\nThe oral vaccine that's arguably received the most attention for Vaxart is VXA-CoV2-1, an early-stage tablet designed to combat the coronavirus disease 2019 (COVID-19). In May, Vaxart announced that its phase 1 study of VXA-CoV2-1 led to clear immune response in participants, although high levels of neutralizing antibodies weren't present. Traditional shot-in-the-arm vaccines have led to high levels of neutralizing antibodies in clinical trials.\nBut Vaxart's work isn't close to being finished. In early August, it received the go-ahead from the U.S. Food and Drug Administration (FDA) to commence an oral-tablet study for a very specific protein to combat COVID-19. It could be some time before investors know if oral vaccines are a viable solution, but the convenience factor certainly makes this trial worth watching.\nImage source: Getty Images.\nCRISPR Technologies: 191,416% implied sales growth by 2025\nDid I mention that clinical-stage biotech stocks are a great source of jaw-dropping growth over the next decade? CRISPR Therapeutics (NASDAQ:CRSP), a company leaning on gene-editing technology to precisely alter genomic DNA and tackle hard-to-treat diseases, is expected to see sales climb from $719,000 in 2020 to a consensus of $1.377 billion by 2025. That's an improvement of more than 191,000% in five years.\nArguably the biggest positive for CRISPR is that it's working with Vertex Pharmaceuticals (NASDAQ:VRTX) in the development of CTX001 for the treatment of transfusion-dependent beta thalassemia (TDT) and sickle cell disease (SCD). Vertex has a storied history of developing novel therapies for hard-to-treat illnesses, such as cystic fibrosis.\nIt also doesn't hurt that Vertex's deep pockets are helping to lift CRISPR's bank account. Following a $900 million collaboration payment in the second quarter, CRISPR was sitting on nearly $2.6 billion in cash, cash equivalents, and marketable securities. That's plenty of capital to fund its ongoing clinical studies.\nInitial trial data for CTX001 has also been encouraging. At the European Hematology Association's annual meeting in June, the company announced that all 15 patients with TDT were transfusion-free after follow-ups of at least three months. TDT patients can require weekly transfusions, depending on the severity of their illnesses. Management believes regulatory filings, assuming all goes well in clinical studies, could come by or before mid-2023.\nWhile CRISPR Technologies is far from the only company looking to tackle TDT and SCD, it's among the best funded and has Vertex in its corner. That gives it a better-than-average chance of success, at least in my book.\nImage source: Getty Images.\nOcugen: 604,551% implied sales growth by 2025\nYet another clinical-stage biotech company expected to see sales go from virtually zero to a big number with a lot of zeroes is Ocugen (NASDAQ:OCGN). After the company reported $43,000 in sales last year, Wall Street's consensus has it generating $260 million in full-year sales by 2025. We're talking about a nearly 605,000% sales increase in five years.\nNot to sound like a broken record, but a COVID-19 vaccine is Ocugen's potential catalyst. The company has partnered with India's Bharat Biotech for the commercialization of Covaxin. A phase 3 trial of 25,800 adults aged 18 and up in India demonstrated a vaccine efficacy of 77.8% for symptomatic infections, 63.6% against asymptomatic infections, and most importantly was 93.4% effective against severe COVID-19 disease. The July-reported data from Bharat also showed a 65.2% efficacy against the delta variant.\nWith so many people left to be vaccinated, this probably sounds like a slam-dunk for some form of emergency authorization use in developed or emerging markets. However, there's a big problem for Ocugen: It only has co-commercialization rights for Covaxin in the U.S. and Canada. The U.S. has ordered more-than-enough vaccines to inoculate all eligible Americans, and likely has doses in reserve should booster shots become necessary. The same could be said for Canada, which invested heavily in vaccine purchases.\nWhile there's no such thing as having too many vaccine options during a pandemic, Covaxin's initial efficacy doesn't pop quite like the vaccines from Moderna, Pfizer/BioNTech, or even Novavax, which looks to be nearing its own emergency use authorization in the United States. Suffice it to say, Ocugen's sales forecast may prove unattainable.\nA rendering of the all-electric Nikola Tre semi. Image source: Nikola.\nNikola: 2,970,426% implied sales growth by 2025\nHowever, the crème de la crème of growth opportunities, at least pertaining to this list, is electric vehicle (EV) manufacturer Nikola (NASDAQ:NKLA). The expectation is that we'll see Nikola's sales catapult from a reported $95,000 in 2020 to a consensus of $2.822 billion by 2025. This equates to almost a 3 million percent jump in annual revenue.\nThe growth opportunity for EVs is pretty straightforward. With developed countries like the U.S. tackling climate change head-on, replacing fossil-fuel-burning vehicles with alternative-energy vehicles is one of the easiest ways to make a difference. It's going to take decades for consumers and businesses to make this shift, which leaves plenty of room for multiple EV manufacturers to thrive.\nThe issue for Nikola is that it's dealing with a public relations mess. Last year, short-side firm Hindenburg Research released a report that alleged Nikola was a fraud. Even though an independent review found that many of Hindenburg's allegations weren't true, it was discovered that founder Trevor Milton's statements regarding pre-sells weren't accurate.\nDespite stepping down last year, Milton was indicted by the U.S. Department of Justice on three charges of misleading investors. Ultimately, Nikola will have to overcome a breach of trust to sell its vehicles, and it likely will need a lot more cash than it has now to build up its production. Personally, I'm skeptical the company will reach this lofty sales consensus by mid-decade.","news_type":1},"isVote":1,"tweetType":1,"viewCount":282,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865520781,"gmtCreate":1633003694238,"gmtModify":1633003694999,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like and commnet&nbsp;","listText":"Like and commnet&nbsp;","text":"Like and commnet","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/865520781","repostId":"1185816399","repostType":4,"repost":{"id":"1185816399","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633002448,"share":"https://www.laohu8.com/m/news/1185816399?lang=&edition=full","pubTime":"2021-09-30 19:47","market":"us","language":"en","title":"Bed Bath & Beyond stock plunged 13.4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1185816399","media":"Tiger Newspress","summary":"Bed Bath & Beyond stock plunged 13.4% in premarket trading after profit and sales miss, weak guidanc","content":"<p>Bed Bath &amp; Beyond stock plunged 13.4% in premarket trading&nbsp;after profit and sales miss, weak guidance.</p>\n<p><img src=\"https://static.tigerbbs.com/00ea5147a2b56519c91eaaf1272dfc80\" tg-width=\"847\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p>\n<p>Bed Bath &amp; Beyond Inc.&nbsp;today reported financial results for the second quarter of fiscal 2021 ended August 28, 2021.</p>\n<p><img src=\"https://static.tigerbbs.com/df0342936dc10bc5e3df9c676baf38be\" tg-width=\"1038\" tg-height=\"377\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Q2 Highlights</b></p>\n<ul>\n <li>Comparable Sales decline of (1)% versus Q2 2020 primarily driven by slower than expected traffic trends in August across stores and digital</li>\n</ul>\n<ul>\n <li>Bed Bath &amp; Beyond banner Comparable Sales decline of (4)%; buybuy BABY banner growth of high-teens percentage</li>\n</ul>\n<ul>\n <li>Core&nbsp;Sales decline of (11)%, primarily due to the impact of fleet optimization</li>\n</ul>\n<ul>\n <li>Gross Margin of 30.3% and Adjusted2 Gross Margin of 34.0%</li>\n</ul>\n<ul>\n <li>Adjusted&nbsp;Gross Margin reflects 170 bps of higher merchandise margin versus last year, that was more than offset by freight cost increases of 360 bps and which were greater than anticipated, particularly at the end of the quarter</li>\n</ul>\n<ul>\n <li>SG&amp;A expense in-line with expectations</li>\n</ul>\n<ul>\n <li>Adjusted&nbsp;EBITDA of $85 million as a result of Net Sales and Adjusted2 Gross Margin performance</li>\n</ul>\n<ul>\n <li>Guidance outlook for 2021 third quarter established</li>\n</ul>\n<ul>\n <li>Revised full fiscal year 2021 guidance outlook to reflect year-to-date performance</li>\n</ul>\n<p>Mark Tritton, Bed Bath &amp; Beyond’s President and CEO said, “While our results this quarter were below expectations, we remain confident in our multi-year transformation. Following solid growth in June, we saw unexpected, external disruptive forces towards the end of the quarter that impacted our outcome. In August, the final and largest month of our second fiscal period, traffic slowed significantly and, therefore, sales did not materialize as we had anticipated. As COVID-19 fears re-emerged amid the on-going Delta variant, we experienced a challenging environment. This was particularly evident in large, key states such as Florida, Texas and California, which represent a substantial portion of our sales. Furthermore, unprecedented supply chain challenges have been impacting the industry pervasively, and we saw steeper cost inflation escalating by month, especially later in the quarter, beyond the significant increases that we had already anticipated. This outpaced our plans to offset these headwinds. These factors impacted sales and gross margin.\"</p>\n<p>Tritton added, \"Encouragingly, we've continued to make progress against the fundamentals of our three-year transformation strategy. Our buybuy BABY banner continued to build on its positive momentum from the past several quarters, growing double digits due to strength in apparel and travel gear and increasing market share for the period. We also celebrated the July re-opening of our Bed Bath &amp; Beyond banner's NYC flagship store in Chelsea as part of our comprehensive store remodel program, which is exceeding our expectations. Our higher margin Owned Brands are outperforming our penetration goals across the overall chain, and even stronger in remodeled stores. As a group, we continued to leverage our enhanced digital channel, with significant growth above 2019 at nearly double the proportion of sales. Operationally, we entered the next phase of our supply chain modernization through our partnership with Ryder which is instrumental to our strategy. We are committed to executing over the short, mid and long term, especially during these early stages of our multi-year plan.\"</p>\n<p>\"Our financial foundation is strong. We generated positive operating cash flow during the quarter. Our cash balance, coupled with our recently amended asset-based revolving credit facility, provides us on-going capital and liquidity strength of $2.0 billion. We are well positioned to continue our planned investments in our business and pave the way towards a more profitable future. We have the plan, the team and the resources to unlock our potential.\"</p>\n<p><b>Fiscal 2021 Third Quarter Outlook</b></p>\n<p>The Company expects fiscal 2021 third quarter Net Sales of between $1.96 billion to $2.0 billion, which only reflects sales from the Company's Core&nbsp;businesses. Net Sales also includes planned sales reductions from divestitures and the Company's store fleet optimization program. On a Comparable Sales basis, the Company expects to be approximately flat compared to the prior year period.</p>\n<p>The Company expects to achieve Adjusted Gross Margin in the range of 34% to 35%. This guidance reflects the impact of anticipated greater global supply chain challenges</p>\n<p>The Company expects Adjusted&nbsp;EBITDA between $80 million to $85 million and Adjusted2 EPS in the range of $0.00 to $0.05 per diluted share for the fiscal 2021 third quarter.</p>\n<p><b>Fiscal Year 2021 Outlook</b></p>\n<p>Based on its year-to-date performance in the fiscal first half of the year, as well as current expectations for the fiscal third quarter, the Company is revising its fiscal year 2021 guidance outlook.</p>\n<p>The Company now expects higher fiscal year 2021 Net Sales of $8.1 billion to $8.3 billion. The Company expects comparable sales of flat to up slightly for the second through fourth quarters of fiscal 2021.</p>\n<p>Adjusted Gross Margin is now anticipated to be in a range of 34.0% to 35.0% and Adjusted SG&amp;A is expected to be approximately 32%.</p>\n<p>The Company now expects Adjusted EBITDA to be in the range of $425 million to $465 million and Adjusted EPS range of $0.70 to $1.10 per diluted share.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bed Bath & Beyond stock plunged 13.4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBed Bath & Beyond stock plunged 13.4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-30 19:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Bed Bath &amp; Beyond stock plunged 13.4% in premarket trading&nbsp;after profit and sales miss, weak guidance.</p>\n<p><img src=\"https://static.tigerbbs.com/00ea5147a2b56519c91eaaf1272dfc80\" tg-width=\"847\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p>\n<p>Bed Bath &amp; Beyond Inc.&nbsp;today reported financial results for the second quarter of fiscal 2021 ended August 28, 2021.</p>\n<p><img src=\"https://static.tigerbbs.com/df0342936dc10bc5e3df9c676baf38be\" tg-width=\"1038\" tg-height=\"377\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Q2 Highlights</b></p>\n<ul>\n <li>Comparable Sales decline of (1)% versus Q2 2020 primarily driven by slower than expected traffic trends in August across stores and digital</li>\n</ul>\n<ul>\n <li>Bed Bath &amp; Beyond banner Comparable Sales decline of (4)%; buybuy BABY banner growth of high-teens percentage</li>\n</ul>\n<ul>\n <li>Core&nbsp;Sales decline of (11)%, primarily due to the impact of fleet optimization</li>\n</ul>\n<ul>\n <li>Gross Margin of 30.3% and Adjusted2 Gross Margin of 34.0%</li>\n</ul>\n<ul>\n <li>Adjusted&nbsp;Gross Margin reflects 170 bps of higher merchandise margin versus last year, that was more than offset by freight cost increases of 360 bps and which were greater than anticipated, particularly at the end of the quarter</li>\n</ul>\n<ul>\n <li>SG&amp;A expense in-line with expectations</li>\n</ul>\n<ul>\n <li>Adjusted&nbsp;EBITDA of $85 million as a result of Net Sales and Adjusted2 Gross Margin performance</li>\n</ul>\n<ul>\n <li>Guidance outlook for 2021 third quarter established</li>\n</ul>\n<ul>\n <li>Revised full fiscal year 2021 guidance outlook to reflect year-to-date performance</li>\n</ul>\n<p>Mark Tritton, Bed Bath &amp; Beyond’s President and CEO said, “While our results this quarter were below expectations, we remain confident in our multi-year transformation. Following solid growth in June, we saw unexpected, external disruptive forces towards the end of the quarter that impacted our outcome. In August, the final and largest month of our second fiscal period, traffic slowed significantly and, therefore, sales did not materialize as we had anticipated. As COVID-19 fears re-emerged amid the on-going Delta variant, we experienced a challenging environment. This was particularly evident in large, key states such as Florida, Texas and California, which represent a substantial portion of our sales. Furthermore, unprecedented supply chain challenges have been impacting the industry pervasively, and we saw steeper cost inflation escalating by month, especially later in the quarter, beyond the significant increases that we had already anticipated. This outpaced our plans to offset these headwinds. These factors impacted sales and gross margin.\"</p>\n<p>Tritton added, \"Encouragingly, we've continued to make progress against the fundamentals of our three-year transformation strategy. Our buybuy BABY banner continued to build on its positive momentum from the past several quarters, growing double digits due to strength in apparel and travel gear and increasing market share for the period. We also celebrated the July re-opening of our Bed Bath &amp; Beyond banner's NYC flagship store in Chelsea as part of our comprehensive store remodel program, which is exceeding our expectations. Our higher margin Owned Brands are outperforming our penetration goals across the overall chain, and even stronger in remodeled stores. As a group, we continued to leverage our enhanced digital channel, with significant growth above 2019 at nearly double the proportion of sales. Operationally, we entered the next phase of our supply chain modernization through our partnership with Ryder which is instrumental to our strategy. We are committed to executing over the short, mid and long term, especially during these early stages of our multi-year plan.\"</p>\n<p>\"Our financial foundation is strong. We generated positive operating cash flow during the quarter. Our cash balance, coupled with our recently amended asset-based revolving credit facility, provides us on-going capital and liquidity strength of $2.0 billion. We are well positioned to continue our planned investments in our business and pave the way towards a more profitable future. We have the plan, the team and the resources to unlock our potential.\"</p>\n<p><b>Fiscal 2021 Third Quarter Outlook</b></p>\n<p>The Company expects fiscal 2021 third quarter Net Sales of between $1.96 billion to $2.0 billion, which only reflects sales from the Company's Core&nbsp;businesses. Net Sales also includes planned sales reductions from divestitures and the Company's store fleet optimization program. On a Comparable Sales basis, the Company expects to be approximately flat compared to the prior year period.</p>\n<p>The Company expects to achieve Adjusted Gross Margin in the range of 34% to 35%. This guidance reflects the impact of anticipated greater global supply chain challenges</p>\n<p>The Company expects Adjusted&nbsp;EBITDA between $80 million to $85 million and Adjusted2 EPS in the range of $0.00 to $0.05 per diluted share for the fiscal 2021 third quarter.</p>\n<p><b>Fiscal Year 2021 Outlook</b></p>\n<p>Based on its year-to-date performance in the fiscal first half of the year, as well as current expectations for the fiscal third quarter, the Company is revising its fiscal year 2021 guidance outlook.</p>\n<p>The Company now expects higher fiscal year 2021 Net Sales of $8.1 billion to $8.3 billion. The Company expects comparable sales of flat to up slightly for the second through fourth quarters of fiscal 2021.</p>\n<p>Adjusted Gross Margin is now anticipated to be in a range of 34.0% to 35.0% and Adjusted SG&amp;A is expected to be approximately 32%.</p>\n<p>The Company now expects Adjusted EBITDA to be in the range of $425 million to $465 million and Adjusted EPS range of $0.70 to $1.10 per diluted share.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BBBY":"3B家居"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185816399","content_text":"Bed Bath & Beyond stock plunged 13.4% in premarket trading after profit and sales miss, weak guidance.\n\nBed Bath & Beyond Inc. today reported financial results for the second quarter of fiscal 2021 ended August 28, 2021.\n\nQ2 Highlights\n\nComparable Sales decline of (1)% versus Q2 2020 primarily driven by slower than expected traffic trends in August across stores and digital\n\n\nBed Bath & Beyond banner Comparable Sales decline of (4)%; buybuy BABY banner growth of high-teens percentage\n\n\nCore Sales decline of (11)%, primarily due to the impact of fleet optimization\n\n\nGross Margin of 30.3% and Adjusted2 Gross Margin of 34.0%\n\n\nAdjusted Gross Margin reflects 170 bps of higher merchandise margin versus last year, that was more than offset by freight cost increases of 360 bps and which were greater than anticipated, particularly at the end of the quarter\n\n\nSG&A expense in-line with expectations\n\n\nAdjusted EBITDA of $85 million as a result of Net Sales and Adjusted2 Gross Margin performance\n\n\nGuidance outlook for 2021 third quarter established\n\n\nRevised full fiscal year 2021 guidance outlook to reflect year-to-date performance\n\nMark Tritton, Bed Bath & Beyond’s President and CEO said, “While our results this quarter were below expectations, we remain confident in our multi-year transformation. Following solid growth in June, we saw unexpected, external disruptive forces towards the end of the quarter that impacted our outcome. In August, the final and largest month of our second fiscal period, traffic slowed significantly and, therefore, sales did not materialize as we had anticipated. As COVID-19 fears re-emerged amid the on-going Delta variant, we experienced a challenging environment. This was particularly evident in large, key states such as Florida, Texas and California, which represent a substantial portion of our sales. Furthermore, unprecedented supply chain challenges have been impacting the industry pervasively, and we saw steeper cost inflation escalating by month, especially later in the quarter, beyond the significant increases that we had already anticipated. This outpaced our plans to offset these headwinds. These factors impacted sales and gross margin.\"\nTritton added, \"Encouragingly, we've continued to make progress against the fundamentals of our three-year transformation strategy. Our buybuy BABY banner continued to build on its positive momentum from the past several quarters, growing double digits due to strength in apparel and travel gear and increasing market share for the period. We also celebrated the July re-opening of our Bed Bath & Beyond banner's NYC flagship store in Chelsea as part of our comprehensive store remodel program, which is exceeding our expectations. Our higher margin Owned Brands are outperforming our penetration goals across the overall chain, and even stronger in remodeled stores. As a group, we continued to leverage our enhanced digital channel, with significant growth above 2019 at nearly double the proportion of sales. Operationally, we entered the next phase of our supply chain modernization through our partnership with Ryder which is instrumental to our strategy. We are committed to executing over the short, mid and long term, especially during these early stages of our multi-year plan.\"\n\"Our financial foundation is strong. We generated positive operating cash flow during the quarter. Our cash balance, coupled with our recently amended asset-based revolving credit facility, provides us on-going capital and liquidity strength of $2.0 billion. We are well positioned to continue our planned investments in our business and pave the way towards a more profitable future. We have the plan, the team and the resources to unlock our potential.\"\nFiscal 2021 Third Quarter Outlook\nThe Company expects fiscal 2021 third quarter Net Sales of between $1.96 billion to $2.0 billion, which only reflects sales from the Company's Core businesses. Net Sales also includes planned sales reductions from divestitures and the Company's store fleet optimization program. On a Comparable Sales basis, the Company expects to be approximately flat compared to the prior year period.\nThe Company expects to achieve Adjusted Gross Margin in the range of 34% to 35%. This guidance reflects the impact of anticipated greater global supply chain challenges\nThe Company expects Adjusted EBITDA between $80 million to $85 million and Adjusted2 EPS in the range of $0.00 to $0.05 per diluted share for the fiscal 2021 third quarter.\nFiscal Year 2021 Outlook\nBased on its year-to-date performance in the fiscal first half of the year, as well as current expectations for the fiscal third quarter, the Company is revising its fiscal year 2021 guidance outlook.\nThe Company now expects higher fiscal year 2021 Net Sales of $8.1 billion to $8.3 billion. The Company expects comparable sales of flat to up slightly for the second through fourth quarters of fiscal 2021.\nAdjusted Gross Margin is now anticipated to be in a range of 34.0% to 35.0% and Adjusted SG&A is expected to be approximately 32%.\nThe Company now expects Adjusted EBITDA to be in the range of $425 million to $465 million and Adjusted EPS range of $0.70 to $1.10 per diluted share.","news_type":1},"isVote":1,"tweetType":1,"viewCount":688,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865520649,"gmtCreate":1633003684215,"gmtModify":1633003685064,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like and comment&nbsp;","listText":"Like and comment&nbsp;","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/865520649","repostId":"1185816399","repostType":4,"repost":{"id":"1185816399","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633002448,"share":"https://www.laohu8.com/m/news/1185816399?lang=&edition=full","pubTime":"2021-09-30 19:47","market":"us","language":"en","title":"Bed Bath & Beyond stock plunged 13.4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1185816399","media":"Tiger Newspress","summary":"Bed Bath & Beyond stock plunged 13.4% in premarket trading after profit and sales miss, weak guidanc","content":"<p>Bed Bath &amp; Beyond stock plunged 13.4% in premarket trading&nbsp;after profit and sales miss, weak guidance.</p>\n<p><img src=\"https://static.tigerbbs.com/00ea5147a2b56519c91eaaf1272dfc80\" tg-width=\"847\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p>\n<p>Bed Bath &amp; Beyond Inc.&nbsp;today reported financial results for the second quarter of fiscal 2021 ended August 28, 2021.</p>\n<p><img src=\"https://static.tigerbbs.com/df0342936dc10bc5e3df9c676baf38be\" tg-width=\"1038\" tg-height=\"377\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Q2 Highlights</b></p>\n<ul>\n <li>Comparable Sales decline of (1)% versus Q2 2020 primarily driven by slower than expected traffic trends in August across stores and digital</li>\n</ul>\n<ul>\n <li>Bed Bath &amp; Beyond banner Comparable Sales decline of (4)%; buybuy BABY banner growth of high-teens percentage</li>\n</ul>\n<ul>\n <li>Core&nbsp;Sales decline of (11)%, primarily due to the impact of fleet optimization</li>\n</ul>\n<ul>\n <li>Gross Margin of 30.3% and Adjusted2 Gross Margin of 34.0%</li>\n</ul>\n<ul>\n <li>Adjusted&nbsp;Gross Margin reflects 170 bps of higher merchandise margin versus last year, that was more than offset by freight cost increases of 360 bps and which were greater than anticipated, particularly at the end of the quarter</li>\n</ul>\n<ul>\n <li>SG&amp;A expense in-line with expectations</li>\n</ul>\n<ul>\n <li>Adjusted&nbsp;EBITDA of $85 million as a result of Net Sales and Adjusted2 Gross Margin performance</li>\n</ul>\n<ul>\n <li>Guidance outlook for 2021 third quarter established</li>\n</ul>\n<ul>\n <li>Revised full fiscal year 2021 guidance outlook to reflect year-to-date performance</li>\n</ul>\n<p>Mark Tritton, Bed Bath &amp; Beyond’s President and CEO said, “While our results this quarter were below expectations, we remain confident in our multi-year transformation. Following solid growth in June, we saw unexpected, external disruptive forces towards the end of the quarter that impacted our outcome. In August, the final and largest month of our second fiscal period, traffic slowed significantly and, therefore, sales did not materialize as we had anticipated. As COVID-19 fears re-emerged amid the on-going Delta variant, we experienced a challenging environment. This was particularly evident in large, key states such as Florida, Texas and California, which represent a substantial portion of our sales. Furthermore, unprecedented supply chain challenges have been impacting the industry pervasively, and we saw steeper cost inflation escalating by month, especially later in the quarter, beyond the significant increases that we had already anticipated. This outpaced our plans to offset these headwinds. These factors impacted sales and gross margin.\"</p>\n<p>Tritton added, \"Encouragingly, we've continued to make progress against the fundamentals of our three-year transformation strategy. Our buybuy BABY banner continued to build on its positive momentum from the past several quarters, growing double digits due to strength in apparel and travel gear and increasing market share for the period. We also celebrated the July re-opening of our Bed Bath &amp; Beyond banner's NYC flagship store in Chelsea as part of our comprehensive store remodel program, which is exceeding our expectations. Our higher margin Owned Brands are outperforming our penetration goals across the overall chain, and even stronger in remodeled stores. As a group, we continued to leverage our enhanced digital channel, with significant growth above 2019 at nearly double the proportion of sales. Operationally, we entered the next phase of our supply chain modernization through our partnership with Ryder which is instrumental to our strategy. We are committed to executing over the short, mid and long term, especially during these early stages of our multi-year plan.\"</p>\n<p>\"Our financial foundation is strong. We generated positive operating cash flow during the quarter. Our cash balance, coupled with our recently amended asset-based revolving credit facility, provides us on-going capital and liquidity strength of $2.0 billion. We are well positioned to continue our planned investments in our business and pave the way towards a more profitable future. We have the plan, the team and the resources to unlock our potential.\"</p>\n<p><b>Fiscal 2021 Third Quarter Outlook</b></p>\n<p>The Company expects fiscal 2021 third quarter Net Sales of between $1.96 billion to $2.0 billion, which only reflects sales from the Company's Core&nbsp;businesses. Net Sales also includes planned sales reductions from divestitures and the Company's store fleet optimization program. On a Comparable Sales basis, the Company expects to be approximately flat compared to the prior year period.</p>\n<p>The Company expects to achieve Adjusted Gross Margin in the range of 34% to 35%. This guidance reflects the impact of anticipated greater global supply chain challenges</p>\n<p>The Company expects Adjusted&nbsp;EBITDA between $80 million to $85 million and Adjusted2 EPS in the range of $0.00 to $0.05 per diluted share for the fiscal 2021 third quarter.</p>\n<p><b>Fiscal Year 2021 Outlook</b></p>\n<p>Based on its year-to-date performance in the fiscal first half of the year, as well as current expectations for the fiscal third quarter, the Company is revising its fiscal year 2021 guidance outlook.</p>\n<p>The Company now expects higher fiscal year 2021 Net Sales of $8.1 billion to $8.3 billion. The Company expects comparable sales of flat to up slightly for the second through fourth quarters of fiscal 2021.</p>\n<p>Adjusted Gross Margin is now anticipated to be in a range of 34.0% to 35.0% and Adjusted SG&amp;A is expected to be approximately 32%.</p>\n<p>The Company now expects Adjusted EBITDA to be in the range of $425 million to $465 million and Adjusted EPS range of $0.70 to $1.10 per diluted share.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bed Bath & Beyond stock plunged 13.4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBed Bath & Beyond stock plunged 13.4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-30 19:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Bed Bath &amp; Beyond stock plunged 13.4% in premarket trading&nbsp;after profit and sales miss, weak guidance.</p>\n<p><img src=\"https://static.tigerbbs.com/00ea5147a2b56519c91eaaf1272dfc80\" tg-width=\"847\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p>\n<p>Bed Bath &amp; Beyond Inc.&nbsp;today reported financial results for the second quarter of fiscal 2021 ended August 28, 2021.</p>\n<p><img src=\"https://static.tigerbbs.com/df0342936dc10bc5e3df9c676baf38be\" tg-width=\"1038\" tg-height=\"377\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Q2 Highlights</b></p>\n<ul>\n <li>Comparable Sales decline of (1)% versus Q2 2020 primarily driven by slower than expected traffic trends in August across stores and digital</li>\n</ul>\n<ul>\n <li>Bed Bath &amp; Beyond banner Comparable Sales decline of (4)%; buybuy BABY banner growth of high-teens percentage</li>\n</ul>\n<ul>\n <li>Core&nbsp;Sales decline of (11)%, primarily due to the impact of fleet optimization</li>\n</ul>\n<ul>\n <li>Gross Margin of 30.3% and Adjusted2 Gross Margin of 34.0%</li>\n</ul>\n<ul>\n <li>Adjusted&nbsp;Gross Margin reflects 170 bps of higher merchandise margin versus last year, that was more than offset by freight cost increases of 360 bps and which were greater than anticipated, particularly at the end of the quarter</li>\n</ul>\n<ul>\n <li>SG&amp;A expense in-line with expectations</li>\n</ul>\n<ul>\n <li>Adjusted&nbsp;EBITDA of $85 million as a result of Net Sales and Adjusted2 Gross Margin performance</li>\n</ul>\n<ul>\n <li>Guidance outlook for 2021 third quarter established</li>\n</ul>\n<ul>\n <li>Revised full fiscal year 2021 guidance outlook to reflect year-to-date performance</li>\n</ul>\n<p>Mark Tritton, Bed Bath &amp; Beyond’s President and CEO said, “While our results this quarter were below expectations, we remain confident in our multi-year transformation. Following solid growth in June, we saw unexpected, external disruptive forces towards the end of the quarter that impacted our outcome. In August, the final and largest month of our second fiscal period, traffic slowed significantly and, therefore, sales did not materialize as we had anticipated. As COVID-19 fears re-emerged amid the on-going Delta variant, we experienced a challenging environment. This was particularly evident in large, key states such as Florida, Texas and California, which represent a substantial portion of our sales. Furthermore, unprecedented supply chain challenges have been impacting the industry pervasively, and we saw steeper cost inflation escalating by month, especially later in the quarter, beyond the significant increases that we had already anticipated. This outpaced our plans to offset these headwinds. These factors impacted sales and gross margin.\"</p>\n<p>Tritton added, \"Encouragingly, we've continued to make progress against the fundamentals of our three-year transformation strategy. Our buybuy BABY banner continued to build on its positive momentum from the past several quarters, growing double digits due to strength in apparel and travel gear and increasing market share for the period. We also celebrated the July re-opening of our Bed Bath &amp; Beyond banner's NYC flagship store in Chelsea as part of our comprehensive store remodel program, which is exceeding our expectations. Our higher margin Owned Brands are outperforming our penetration goals across the overall chain, and even stronger in remodeled stores. As a group, we continued to leverage our enhanced digital channel, with significant growth above 2019 at nearly double the proportion of sales. Operationally, we entered the next phase of our supply chain modernization through our partnership with Ryder which is instrumental to our strategy. We are committed to executing over the short, mid and long term, especially during these early stages of our multi-year plan.\"</p>\n<p>\"Our financial foundation is strong. We generated positive operating cash flow during the quarter. Our cash balance, coupled with our recently amended asset-based revolving credit facility, provides us on-going capital and liquidity strength of $2.0 billion. We are well positioned to continue our planned investments in our business and pave the way towards a more profitable future. We have the plan, the team and the resources to unlock our potential.\"</p>\n<p><b>Fiscal 2021 Third Quarter Outlook</b></p>\n<p>The Company expects fiscal 2021 third quarter Net Sales of between $1.96 billion to $2.0 billion, which only reflects sales from the Company's Core&nbsp;businesses. Net Sales also includes planned sales reductions from divestitures and the Company's store fleet optimization program. On a Comparable Sales basis, the Company expects to be approximately flat compared to the prior year period.</p>\n<p>The Company expects to achieve Adjusted Gross Margin in the range of 34% to 35%. This guidance reflects the impact of anticipated greater global supply chain challenges</p>\n<p>The Company expects Adjusted&nbsp;EBITDA between $80 million to $85 million and Adjusted2 EPS in the range of $0.00 to $0.05 per diluted share for the fiscal 2021 third quarter.</p>\n<p><b>Fiscal Year 2021 Outlook</b></p>\n<p>Based on its year-to-date performance in the fiscal first half of the year, as well as current expectations for the fiscal third quarter, the Company is revising its fiscal year 2021 guidance outlook.</p>\n<p>The Company now expects higher fiscal year 2021 Net Sales of $8.1 billion to $8.3 billion. The Company expects comparable sales of flat to up slightly for the second through fourth quarters of fiscal 2021.</p>\n<p>Adjusted Gross Margin is now anticipated to be in a range of 34.0% to 35.0% and Adjusted SG&amp;A is expected to be approximately 32%.</p>\n<p>The Company now expects Adjusted EBITDA to be in the range of $425 million to $465 million and Adjusted EPS range of $0.70 to $1.10 per diluted share.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BBBY":"3B家居"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185816399","content_text":"Bed Bath & Beyond stock plunged 13.4% in premarket trading after profit and sales miss, weak guidance.\n\nBed Bath & Beyond Inc. today reported financial results for the second quarter of fiscal 2021 ended August 28, 2021.\n\nQ2 Highlights\n\nComparable Sales decline of (1)% versus Q2 2020 primarily driven by slower than expected traffic trends in August across stores and digital\n\n\nBed Bath & Beyond banner Comparable Sales decline of (4)%; buybuy BABY banner growth of high-teens percentage\n\n\nCore Sales decline of (11)%, primarily due to the impact of fleet optimization\n\n\nGross Margin of 30.3% and Adjusted2 Gross Margin of 34.0%\n\n\nAdjusted Gross Margin reflects 170 bps of higher merchandise margin versus last year, that was more than offset by freight cost increases of 360 bps and which were greater than anticipated, particularly at the end of the quarter\n\n\nSG&A expense in-line with expectations\n\n\nAdjusted EBITDA of $85 million as a result of Net Sales and Adjusted2 Gross Margin performance\n\n\nGuidance outlook for 2021 third quarter established\n\n\nRevised full fiscal year 2021 guidance outlook to reflect year-to-date performance\n\nMark Tritton, Bed Bath & Beyond’s President and CEO said, “While our results this quarter were below expectations, we remain confident in our multi-year transformation. Following solid growth in June, we saw unexpected, external disruptive forces towards the end of the quarter that impacted our outcome. In August, the final and largest month of our second fiscal period, traffic slowed significantly and, therefore, sales did not materialize as we had anticipated. As COVID-19 fears re-emerged amid the on-going Delta variant, we experienced a challenging environment. This was particularly evident in large, key states such as Florida, Texas and California, which represent a substantial portion of our sales. Furthermore, unprecedented supply chain challenges have been impacting the industry pervasively, and we saw steeper cost inflation escalating by month, especially later in the quarter, beyond the significant increases that we had already anticipated. This outpaced our plans to offset these headwinds. These factors impacted sales and gross margin.\"\nTritton added, \"Encouragingly, we've continued to make progress against the fundamentals of our three-year transformation strategy. Our buybuy BABY banner continued to build on its positive momentum from the past several quarters, growing double digits due to strength in apparel and travel gear and increasing market share for the period. We also celebrated the July re-opening of our Bed Bath & Beyond banner's NYC flagship store in Chelsea as part of our comprehensive store remodel program, which is exceeding our expectations. Our higher margin Owned Brands are outperforming our penetration goals across the overall chain, and even stronger in remodeled stores. As a group, we continued to leverage our enhanced digital channel, with significant growth above 2019 at nearly double the proportion of sales. Operationally, we entered the next phase of our supply chain modernization through our partnership with Ryder which is instrumental to our strategy. We are committed to executing over the short, mid and long term, especially during these early stages of our multi-year plan.\"\n\"Our financial foundation is strong. We generated positive operating cash flow during the quarter. Our cash balance, coupled with our recently amended asset-based revolving credit facility, provides us on-going capital and liquidity strength of $2.0 billion. We are well positioned to continue our planned investments in our business and pave the way towards a more profitable future. We have the plan, the team and the resources to unlock our potential.\"\nFiscal 2021 Third Quarter Outlook\nThe Company expects fiscal 2021 third quarter Net Sales of between $1.96 billion to $2.0 billion, which only reflects sales from the Company's Core businesses. Net Sales also includes planned sales reductions from divestitures and the Company's store fleet optimization program. On a Comparable Sales basis, the Company expects to be approximately flat compared to the prior year period.\nThe Company expects to achieve Adjusted Gross Margin in the range of 34% to 35%. This guidance reflects the impact of anticipated greater global supply chain challenges\nThe Company expects Adjusted EBITDA between $80 million to $85 million and Adjusted2 EPS in the range of $0.00 to $0.05 per diluted share for the fiscal 2021 third quarter.\nFiscal Year 2021 Outlook\nBased on its year-to-date performance in the fiscal first half of the year, as well as current expectations for the fiscal third quarter, the Company is revising its fiscal year 2021 guidance outlook.\nThe Company now expects higher fiscal year 2021 Net Sales of $8.1 billion to $8.3 billion. The Company expects comparable sales of flat to up slightly for the second through fourth quarters of fiscal 2021.\nAdjusted Gross Margin is now anticipated to be in a range of 34.0% to 35.0% and Adjusted SG&A is expected to be approximately 32%.\nThe Company now expects Adjusted EBITDA to be in the range of $425 million to $465 million and Adjusted EPS range of $0.70 to $1.10 per diluted share.","news_type":1},"isVote":1,"tweetType":1,"viewCount":428,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865567792,"gmtCreate":1633003648564,"gmtModify":1633003649314,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>well","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>well","text":"$Palantir Technologies Inc.(PLTR)$well","images":[{"img":"https://static.tigerbbs.com/86329bdcba7308c7be27a96b726946f2","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865567792","isVote":1,"tweetType":1,"viewCount":570,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":865006108,"gmtCreate":1632921673480,"gmtModify":1632921674272,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>buy when low","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>buy when low","text":"$Alibaba(BABA)$buy when low","images":[{"img":"https://static.tigerbbs.com/224b71698fc48d38343d2dbb2f229eed","width":"1080","height":"3355"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/865006108","isVote":1,"tweetType":1,"viewCount":279,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":865008440,"gmtCreate":1632921642056,"gmtModify":1632925025896,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PRPO\">$Precipio, Inc.(PRPO)$</a>zzzzzz","listText":"<a href=\"https://laohu8.com/S/PRPO\">$Precipio, Inc.(PRPO)$</a>zzzzzz","text":"$Precipio, Inc.(PRPO)$zzzzzz","images":[{"img":"https://static.tigerbbs.com/9abfb87b6bdf83a9b5a4574221ff1c78","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865008440","isVote":1,"tweetType":1,"viewCount":256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":862967619,"gmtCreate":1632831069365,"gmtModify":1632831069591,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PRPO\">$Precipio, Inc.(PRPO)$</a>omg","listText":"<a href=\"https://laohu8.com/S/PRPO\">$Precipio, Inc.(PRPO)$</a>omg","text":"$Precipio, Inc.(PRPO)$omg","images":[{"img":"https://static.tigerbbs.com/85931d80a9c701c224ac86e0bc7bcf6b","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/862967619","isVote":1,"tweetType":1,"viewCount":157,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":866880378,"gmtCreate":1632752985994,"gmtModify":1632798079569,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>$1","listText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>$1","text":"$Naked Brand(NAKD)$$1","images":[{"img":"https://static.tigerbbs.com/057d1fb004ff1ed6e685d532b1ffbd2e","width":"1080","height":"3075"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":1,"link":"https://laohu8.com/post/866880378","isVote":1,"tweetType":1,"viewCount":512,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":866817515,"gmtCreate":1632752961937,"gmtModify":1632798080189,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>kkkkk","listText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>kkkkk","text":"$Cerebain Biotech Corp.(CBBT)$kkkkk","images":[{"img":"https://static.tigerbbs.com/cbb0e122e1ccd81847d75df07dda9431","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/866817515","isVote":1,"tweetType":1,"viewCount":239,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":868561276,"gmtCreate":1632673193295,"gmtModify":1632798649807,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>yess","listText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>yess","text":"$Cerebain Biotech Corp.(CBBT)$yess","images":[{"img":"https://static.tigerbbs.com/cbb0e122e1ccd81847d75df07dda9431","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/868561276","isVote":1,"tweetType":1,"viewCount":221,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":868561888,"gmtCreate":1632673167244,"gmtModify":1632798650049,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>whoooooooop","listText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>whoooooooop","text":"$Naked Brand(NAKD)$whoooooooop","images":[{"img":"https://static.tigerbbs.com/793ab7775ff50a91f352d98bdb4ac4ef","width":"1080","height":"3162"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/868561888","isVote":1,"tweetType":1,"viewCount":256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":868689394,"gmtCreate":1632639341818,"gmtModify":1632647278336,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>haha","listText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>haha","text":"$Cerebain Biotech Corp.(CBBT)$haha","images":[{"img":"https://static.tigerbbs.com/cbb0e122e1ccd81847d75df07dda9431","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/868689394","isVote":1,"tweetType":1,"viewCount":98,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":868330238,"gmtCreate":1632591100224,"gmtModify":1632654413335,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>yes","listText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>yes","text":"$Cerebain Biotech Corp.(CBBT)$yes","images":[{"img":"https://static.tigerbbs.com/cbb0e122e1ccd81847d75df07dda9431","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/868330238","isVote":1,"tweetType":1,"viewCount":169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":868330602,"gmtCreate":1632591090206,"gmtModify":1632654416336,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>yes","listText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>yes","text":"$Cerebain Biotech Corp.(CBBT)$yes","images":[{"img":"https://static.tigerbbs.com/d8f51b73b84fd1c3af3c677abfe6ff36","width":"1080","height":"3075"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/868330602","isVote":1,"tweetType":1,"viewCount":223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"hots":[{"id":865520781,"gmtCreate":1633003694238,"gmtModify":1633003694999,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like and commnet&nbsp;","listText":"Like and commnet&nbsp;","text":"Like and commnet","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/865520781","repostId":"1185816399","repostType":4,"repost":{"id":"1185816399","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633002448,"share":"https://www.laohu8.com/m/news/1185816399?lang=&edition=full","pubTime":"2021-09-30 19:47","market":"us","language":"en","title":"Bed Bath & Beyond stock plunged 13.4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1185816399","media":"Tiger Newspress","summary":"Bed Bath & Beyond stock plunged 13.4% in premarket trading after profit and sales miss, weak guidanc","content":"<p>Bed Bath &amp; Beyond stock plunged 13.4% in premarket trading&nbsp;after profit and sales miss, weak guidance.</p>\n<p><img src=\"https://static.tigerbbs.com/00ea5147a2b56519c91eaaf1272dfc80\" tg-width=\"847\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p>\n<p>Bed Bath &amp; Beyond Inc.&nbsp;today reported financial results for the second quarter of fiscal 2021 ended August 28, 2021.</p>\n<p><img src=\"https://static.tigerbbs.com/df0342936dc10bc5e3df9c676baf38be\" tg-width=\"1038\" tg-height=\"377\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Q2 Highlights</b></p>\n<ul>\n <li>Comparable Sales decline of (1)% versus Q2 2020 primarily driven by slower than expected traffic trends in August across stores and digital</li>\n</ul>\n<ul>\n <li>Bed Bath &amp; Beyond banner Comparable Sales decline of (4)%; buybuy BABY banner growth of high-teens percentage</li>\n</ul>\n<ul>\n <li>Core&nbsp;Sales decline of (11)%, primarily due to the impact of fleet optimization</li>\n</ul>\n<ul>\n <li>Gross Margin of 30.3% and Adjusted2 Gross Margin of 34.0%</li>\n</ul>\n<ul>\n <li>Adjusted&nbsp;Gross Margin reflects 170 bps of higher merchandise margin versus last year, that was more than offset by freight cost increases of 360 bps and which were greater than anticipated, particularly at the end of the quarter</li>\n</ul>\n<ul>\n <li>SG&amp;A expense in-line with expectations</li>\n</ul>\n<ul>\n <li>Adjusted&nbsp;EBITDA of $85 million as a result of Net Sales and Adjusted2 Gross Margin performance</li>\n</ul>\n<ul>\n <li>Guidance outlook for 2021 third quarter established</li>\n</ul>\n<ul>\n <li>Revised full fiscal year 2021 guidance outlook to reflect year-to-date performance</li>\n</ul>\n<p>Mark Tritton, Bed Bath &amp; Beyond’s President and CEO said, “While our results this quarter were below expectations, we remain confident in our multi-year transformation. Following solid growth in June, we saw unexpected, external disruptive forces towards the end of the quarter that impacted our outcome. In August, the final and largest month of our second fiscal period, traffic slowed significantly and, therefore, sales did not materialize as we had anticipated. As COVID-19 fears re-emerged amid the on-going Delta variant, we experienced a challenging environment. This was particularly evident in large, key states such as Florida, Texas and California, which represent a substantial portion of our sales. Furthermore, unprecedented supply chain challenges have been impacting the industry pervasively, and we saw steeper cost inflation escalating by month, especially later in the quarter, beyond the significant increases that we had already anticipated. This outpaced our plans to offset these headwinds. These factors impacted sales and gross margin.\"</p>\n<p>Tritton added, \"Encouragingly, we've continued to make progress against the fundamentals of our three-year transformation strategy. Our buybuy BABY banner continued to build on its positive momentum from the past several quarters, growing double digits due to strength in apparel and travel gear and increasing market share for the period. We also celebrated the July re-opening of our Bed Bath &amp; Beyond banner's NYC flagship store in Chelsea as part of our comprehensive store remodel program, which is exceeding our expectations. Our higher margin Owned Brands are outperforming our penetration goals across the overall chain, and even stronger in remodeled stores. As a group, we continued to leverage our enhanced digital channel, with significant growth above 2019 at nearly double the proportion of sales. Operationally, we entered the next phase of our supply chain modernization through our partnership with Ryder which is instrumental to our strategy. We are committed to executing over the short, mid and long term, especially during these early stages of our multi-year plan.\"</p>\n<p>\"Our financial foundation is strong. We generated positive operating cash flow during the quarter. Our cash balance, coupled with our recently amended asset-based revolving credit facility, provides us on-going capital and liquidity strength of $2.0 billion. We are well positioned to continue our planned investments in our business and pave the way towards a more profitable future. We have the plan, the team and the resources to unlock our potential.\"</p>\n<p><b>Fiscal 2021 Third Quarter Outlook</b></p>\n<p>The Company expects fiscal 2021 third quarter Net Sales of between $1.96 billion to $2.0 billion, which only reflects sales from the Company's Core&nbsp;businesses. Net Sales also includes planned sales reductions from divestitures and the Company's store fleet optimization program. On a Comparable Sales basis, the Company expects to be approximately flat compared to the prior year period.</p>\n<p>The Company expects to achieve Adjusted Gross Margin in the range of 34% to 35%. This guidance reflects the impact of anticipated greater global supply chain challenges</p>\n<p>The Company expects Adjusted&nbsp;EBITDA between $80 million to $85 million and Adjusted2 EPS in the range of $0.00 to $0.05 per diluted share for the fiscal 2021 third quarter.</p>\n<p><b>Fiscal Year 2021 Outlook</b></p>\n<p>Based on its year-to-date performance in the fiscal first half of the year, as well as current expectations for the fiscal third quarter, the Company is revising its fiscal year 2021 guidance outlook.</p>\n<p>The Company now expects higher fiscal year 2021 Net Sales of $8.1 billion to $8.3 billion. The Company expects comparable sales of flat to up slightly for the second through fourth quarters of fiscal 2021.</p>\n<p>Adjusted Gross Margin is now anticipated to be in a range of 34.0% to 35.0% and Adjusted SG&amp;A is expected to be approximately 32%.</p>\n<p>The Company now expects Adjusted EBITDA to be in the range of $425 million to $465 million and Adjusted EPS range of $0.70 to $1.10 per diluted share.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bed Bath & Beyond stock plunged 13.4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBed Bath & Beyond stock plunged 13.4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-30 19:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Bed Bath &amp; Beyond stock plunged 13.4% in premarket trading&nbsp;after profit and sales miss, weak guidance.</p>\n<p><img src=\"https://static.tigerbbs.com/00ea5147a2b56519c91eaaf1272dfc80\" tg-width=\"847\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p>\n<p>Bed Bath &amp; Beyond Inc.&nbsp;today reported financial results for the second quarter of fiscal 2021 ended August 28, 2021.</p>\n<p><img src=\"https://static.tigerbbs.com/df0342936dc10bc5e3df9c676baf38be\" tg-width=\"1038\" tg-height=\"377\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Q2 Highlights</b></p>\n<ul>\n <li>Comparable Sales decline of (1)% versus Q2 2020 primarily driven by slower than expected traffic trends in August across stores and digital</li>\n</ul>\n<ul>\n <li>Bed Bath &amp; Beyond banner Comparable Sales decline of (4)%; buybuy BABY banner growth of high-teens percentage</li>\n</ul>\n<ul>\n <li>Core&nbsp;Sales decline of (11)%, primarily due to the impact of fleet optimization</li>\n</ul>\n<ul>\n <li>Gross Margin of 30.3% and Adjusted2 Gross Margin of 34.0%</li>\n</ul>\n<ul>\n <li>Adjusted&nbsp;Gross Margin reflects 170 bps of higher merchandise margin versus last year, that was more than offset by freight cost increases of 360 bps and which were greater than anticipated, particularly at the end of the quarter</li>\n</ul>\n<ul>\n <li>SG&amp;A expense in-line with expectations</li>\n</ul>\n<ul>\n <li>Adjusted&nbsp;EBITDA of $85 million as a result of Net Sales and Adjusted2 Gross Margin performance</li>\n</ul>\n<ul>\n <li>Guidance outlook for 2021 third quarter established</li>\n</ul>\n<ul>\n <li>Revised full fiscal year 2021 guidance outlook to reflect year-to-date performance</li>\n</ul>\n<p>Mark Tritton, Bed Bath &amp; Beyond’s President and CEO said, “While our results this quarter were below expectations, we remain confident in our multi-year transformation. Following solid growth in June, we saw unexpected, external disruptive forces towards the end of the quarter that impacted our outcome. In August, the final and largest month of our second fiscal period, traffic slowed significantly and, therefore, sales did not materialize as we had anticipated. As COVID-19 fears re-emerged amid the on-going Delta variant, we experienced a challenging environment. This was particularly evident in large, key states such as Florida, Texas and California, which represent a substantial portion of our sales. Furthermore, unprecedented supply chain challenges have been impacting the industry pervasively, and we saw steeper cost inflation escalating by month, especially later in the quarter, beyond the significant increases that we had already anticipated. This outpaced our plans to offset these headwinds. These factors impacted sales and gross margin.\"</p>\n<p>Tritton added, \"Encouragingly, we've continued to make progress against the fundamentals of our three-year transformation strategy. Our buybuy BABY banner continued to build on its positive momentum from the past several quarters, growing double digits due to strength in apparel and travel gear and increasing market share for the period. We also celebrated the July re-opening of our Bed Bath &amp; Beyond banner's NYC flagship store in Chelsea as part of our comprehensive store remodel program, which is exceeding our expectations. Our higher margin Owned Brands are outperforming our penetration goals across the overall chain, and even stronger in remodeled stores. As a group, we continued to leverage our enhanced digital channel, with significant growth above 2019 at nearly double the proportion of sales. Operationally, we entered the next phase of our supply chain modernization through our partnership with Ryder which is instrumental to our strategy. We are committed to executing over the short, mid and long term, especially during these early stages of our multi-year plan.\"</p>\n<p>\"Our financial foundation is strong. We generated positive operating cash flow during the quarter. Our cash balance, coupled with our recently amended asset-based revolving credit facility, provides us on-going capital and liquidity strength of $2.0 billion. We are well positioned to continue our planned investments in our business and pave the way towards a more profitable future. We have the plan, the team and the resources to unlock our potential.\"</p>\n<p><b>Fiscal 2021 Third Quarter Outlook</b></p>\n<p>The Company expects fiscal 2021 third quarter Net Sales of between $1.96 billion to $2.0 billion, which only reflects sales from the Company's Core&nbsp;businesses. Net Sales also includes planned sales reductions from divestitures and the Company's store fleet optimization program. On a Comparable Sales basis, the Company expects to be approximately flat compared to the prior year period.</p>\n<p>The Company expects to achieve Adjusted Gross Margin in the range of 34% to 35%. This guidance reflects the impact of anticipated greater global supply chain challenges</p>\n<p>The Company expects Adjusted&nbsp;EBITDA between $80 million to $85 million and Adjusted2 EPS in the range of $0.00 to $0.05 per diluted share for the fiscal 2021 third quarter.</p>\n<p><b>Fiscal Year 2021 Outlook</b></p>\n<p>Based on its year-to-date performance in the fiscal first half of the year, as well as current expectations for the fiscal third quarter, the Company is revising its fiscal year 2021 guidance outlook.</p>\n<p>The Company now expects higher fiscal year 2021 Net Sales of $8.1 billion to $8.3 billion. The Company expects comparable sales of flat to up slightly for the second through fourth quarters of fiscal 2021.</p>\n<p>Adjusted Gross Margin is now anticipated to be in a range of 34.0% to 35.0% and Adjusted SG&amp;A is expected to be approximately 32%.</p>\n<p>The Company now expects Adjusted EBITDA to be in the range of $425 million to $465 million and Adjusted EPS range of $0.70 to $1.10 per diluted share.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BBBY":"3B家居"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185816399","content_text":"Bed Bath & Beyond stock plunged 13.4% in premarket trading after profit and sales miss, weak guidance.\n\nBed Bath & Beyond Inc. today reported financial results for the second quarter of fiscal 2021 ended August 28, 2021.\n\nQ2 Highlights\n\nComparable Sales decline of (1)% versus Q2 2020 primarily driven by slower than expected traffic trends in August across stores and digital\n\n\nBed Bath & Beyond banner Comparable Sales decline of (4)%; buybuy BABY banner growth of high-teens percentage\n\n\nCore Sales decline of (11)%, primarily due to the impact of fleet optimization\n\n\nGross Margin of 30.3% and Adjusted2 Gross Margin of 34.0%\n\n\nAdjusted Gross Margin reflects 170 bps of higher merchandise margin versus last year, that was more than offset by freight cost increases of 360 bps and which were greater than anticipated, particularly at the end of the quarter\n\n\nSG&A expense in-line with expectations\n\n\nAdjusted EBITDA of $85 million as a result of Net Sales and Adjusted2 Gross Margin performance\n\n\nGuidance outlook for 2021 third quarter established\n\n\nRevised full fiscal year 2021 guidance outlook to reflect year-to-date performance\n\nMark Tritton, Bed Bath & Beyond’s President and CEO said, “While our results this quarter were below expectations, we remain confident in our multi-year transformation. Following solid growth in June, we saw unexpected, external disruptive forces towards the end of the quarter that impacted our outcome. In August, the final and largest month of our second fiscal period, traffic slowed significantly and, therefore, sales did not materialize as we had anticipated. As COVID-19 fears re-emerged amid the on-going Delta variant, we experienced a challenging environment. This was particularly evident in large, key states such as Florida, Texas and California, which represent a substantial portion of our sales. Furthermore, unprecedented supply chain challenges have been impacting the industry pervasively, and we saw steeper cost inflation escalating by month, especially later in the quarter, beyond the significant increases that we had already anticipated. This outpaced our plans to offset these headwinds. These factors impacted sales and gross margin.\"\nTritton added, \"Encouragingly, we've continued to make progress against the fundamentals of our three-year transformation strategy. Our buybuy BABY banner continued to build on its positive momentum from the past several quarters, growing double digits due to strength in apparel and travel gear and increasing market share for the period. We also celebrated the July re-opening of our Bed Bath & Beyond banner's NYC flagship store in Chelsea as part of our comprehensive store remodel program, which is exceeding our expectations. Our higher margin Owned Brands are outperforming our penetration goals across the overall chain, and even stronger in remodeled stores. As a group, we continued to leverage our enhanced digital channel, with significant growth above 2019 at nearly double the proportion of sales. Operationally, we entered the next phase of our supply chain modernization through our partnership with Ryder which is instrumental to our strategy. We are committed to executing over the short, mid and long term, especially during these early stages of our multi-year plan.\"\n\"Our financial foundation is strong. We generated positive operating cash flow during the quarter. Our cash balance, coupled with our recently amended asset-based revolving credit facility, provides us on-going capital and liquidity strength of $2.0 billion. We are well positioned to continue our planned investments in our business and pave the way towards a more profitable future. We have the plan, the team and the resources to unlock our potential.\"\nFiscal 2021 Third Quarter Outlook\nThe Company expects fiscal 2021 third quarter Net Sales of between $1.96 billion to $2.0 billion, which only reflects sales from the Company's Core businesses. Net Sales also includes planned sales reductions from divestitures and the Company's store fleet optimization program. On a Comparable Sales basis, the Company expects to be approximately flat compared to the prior year period.\nThe Company expects to achieve Adjusted Gross Margin in the range of 34% to 35%. This guidance reflects the impact of anticipated greater global supply chain challenges\nThe Company expects Adjusted EBITDA between $80 million to $85 million and Adjusted2 EPS in the range of $0.00 to $0.05 per diluted share for the fiscal 2021 third quarter.\nFiscal Year 2021 Outlook\nBased on its year-to-date performance in the fiscal first half of the year, as well as current expectations for the fiscal third quarter, the Company is revising its fiscal year 2021 guidance outlook.\nThe Company now expects higher fiscal year 2021 Net Sales of $8.1 billion to $8.3 billion. The Company expects comparable sales of flat to up slightly for the second through fourth quarters of fiscal 2021.\nAdjusted Gross Margin is now anticipated to be in a range of 34.0% to 35.0% and Adjusted SG&A is expected to be approximately 32%.\nThe Company now expects Adjusted EBITDA to be in the range of $425 million to $465 million and Adjusted EPS range of $0.70 to $1.10 per diluted share.","news_type":1},"isVote":1,"tweetType":1,"viewCount":688,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865520649,"gmtCreate":1633003684215,"gmtModify":1633003685064,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like and comment&nbsp;","listText":"Like and comment&nbsp;","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/865520649","repostId":"1185816399","repostType":4,"repost":{"id":"1185816399","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633002448,"share":"https://www.laohu8.com/m/news/1185816399?lang=&edition=full","pubTime":"2021-09-30 19:47","market":"us","language":"en","title":"Bed Bath & Beyond stock plunged 13.4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1185816399","media":"Tiger Newspress","summary":"Bed Bath & Beyond stock plunged 13.4% in premarket trading after profit and sales miss, weak guidanc","content":"<p>Bed Bath &amp; Beyond stock plunged 13.4% in premarket trading&nbsp;after profit and sales miss, weak guidance.</p>\n<p><img src=\"https://static.tigerbbs.com/00ea5147a2b56519c91eaaf1272dfc80\" tg-width=\"847\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p>\n<p>Bed Bath &amp; Beyond Inc.&nbsp;today reported financial results for the second quarter of fiscal 2021 ended August 28, 2021.</p>\n<p><img src=\"https://static.tigerbbs.com/df0342936dc10bc5e3df9c676baf38be\" tg-width=\"1038\" tg-height=\"377\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Q2 Highlights</b></p>\n<ul>\n <li>Comparable Sales decline of (1)% versus Q2 2020 primarily driven by slower than expected traffic trends in August across stores and digital</li>\n</ul>\n<ul>\n <li>Bed Bath &amp; Beyond banner Comparable Sales decline of (4)%; buybuy BABY banner growth of high-teens percentage</li>\n</ul>\n<ul>\n <li>Core&nbsp;Sales decline of (11)%, primarily due to the impact of fleet optimization</li>\n</ul>\n<ul>\n <li>Gross Margin of 30.3% and Adjusted2 Gross Margin of 34.0%</li>\n</ul>\n<ul>\n <li>Adjusted&nbsp;Gross Margin reflects 170 bps of higher merchandise margin versus last year, that was more than offset by freight cost increases of 360 bps and which were greater than anticipated, particularly at the end of the quarter</li>\n</ul>\n<ul>\n <li>SG&amp;A expense in-line with expectations</li>\n</ul>\n<ul>\n <li>Adjusted&nbsp;EBITDA of $85 million as a result of Net Sales and Adjusted2 Gross Margin performance</li>\n</ul>\n<ul>\n <li>Guidance outlook for 2021 third quarter established</li>\n</ul>\n<ul>\n <li>Revised full fiscal year 2021 guidance outlook to reflect year-to-date performance</li>\n</ul>\n<p>Mark Tritton, Bed Bath &amp; Beyond’s President and CEO said, “While our results this quarter were below expectations, we remain confident in our multi-year transformation. Following solid growth in June, we saw unexpected, external disruptive forces towards the end of the quarter that impacted our outcome. In August, the final and largest month of our second fiscal period, traffic slowed significantly and, therefore, sales did not materialize as we had anticipated. As COVID-19 fears re-emerged amid the on-going Delta variant, we experienced a challenging environment. This was particularly evident in large, key states such as Florida, Texas and California, which represent a substantial portion of our sales. Furthermore, unprecedented supply chain challenges have been impacting the industry pervasively, and we saw steeper cost inflation escalating by month, especially later in the quarter, beyond the significant increases that we had already anticipated. This outpaced our plans to offset these headwinds. These factors impacted sales and gross margin.\"</p>\n<p>Tritton added, \"Encouragingly, we've continued to make progress against the fundamentals of our three-year transformation strategy. Our buybuy BABY banner continued to build on its positive momentum from the past several quarters, growing double digits due to strength in apparel and travel gear and increasing market share for the period. We also celebrated the July re-opening of our Bed Bath &amp; Beyond banner's NYC flagship store in Chelsea as part of our comprehensive store remodel program, which is exceeding our expectations. Our higher margin Owned Brands are outperforming our penetration goals across the overall chain, and even stronger in remodeled stores. As a group, we continued to leverage our enhanced digital channel, with significant growth above 2019 at nearly double the proportion of sales. Operationally, we entered the next phase of our supply chain modernization through our partnership with Ryder which is instrumental to our strategy. We are committed to executing over the short, mid and long term, especially during these early stages of our multi-year plan.\"</p>\n<p>\"Our financial foundation is strong. We generated positive operating cash flow during the quarter. Our cash balance, coupled with our recently amended asset-based revolving credit facility, provides us on-going capital and liquidity strength of $2.0 billion. We are well positioned to continue our planned investments in our business and pave the way towards a more profitable future. We have the plan, the team and the resources to unlock our potential.\"</p>\n<p><b>Fiscal 2021 Third Quarter Outlook</b></p>\n<p>The Company expects fiscal 2021 third quarter Net Sales of between $1.96 billion to $2.0 billion, which only reflects sales from the Company's Core&nbsp;businesses. Net Sales also includes planned sales reductions from divestitures and the Company's store fleet optimization program. On a Comparable Sales basis, the Company expects to be approximately flat compared to the prior year period.</p>\n<p>The Company expects to achieve Adjusted Gross Margin in the range of 34% to 35%. This guidance reflects the impact of anticipated greater global supply chain challenges</p>\n<p>The Company expects Adjusted&nbsp;EBITDA between $80 million to $85 million and Adjusted2 EPS in the range of $0.00 to $0.05 per diluted share for the fiscal 2021 third quarter.</p>\n<p><b>Fiscal Year 2021 Outlook</b></p>\n<p>Based on its year-to-date performance in the fiscal first half of the year, as well as current expectations for the fiscal third quarter, the Company is revising its fiscal year 2021 guidance outlook.</p>\n<p>The Company now expects higher fiscal year 2021 Net Sales of $8.1 billion to $8.3 billion. The Company expects comparable sales of flat to up slightly for the second through fourth quarters of fiscal 2021.</p>\n<p>Adjusted Gross Margin is now anticipated to be in a range of 34.0% to 35.0% and Adjusted SG&amp;A is expected to be approximately 32%.</p>\n<p>The Company now expects Adjusted EBITDA to be in the range of $425 million to $465 million and Adjusted EPS range of $0.70 to $1.10 per diluted share.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bed Bath & Beyond stock plunged 13.4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBed Bath & Beyond stock plunged 13.4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-30 19:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Bed Bath &amp; Beyond stock plunged 13.4% in premarket trading&nbsp;after profit and sales miss, weak guidance.</p>\n<p><img src=\"https://static.tigerbbs.com/00ea5147a2b56519c91eaaf1272dfc80\" tg-width=\"847\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p>\n<p>Bed Bath &amp; Beyond Inc.&nbsp;today reported financial results for the second quarter of fiscal 2021 ended August 28, 2021.</p>\n<p><img src=\"https://static.tigerbbs.com/df0342936dc10bc5e3df9c676baf38be\" tg-width=\"1038\" tg-height=\"377\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Q2 Highlights</b></p>\n<ul>\n <li>Comparable Sales decline of (1)% versus Q2 2020 primarily driven by slower than expected traffic trends in August across stores and digital</li>\n</ul>\n<ul>\n <li>Bed Bath &amp; Beyond banner Comparable Sales decline of (4)%; buybuy BABY banner growth of high-teens percentage</li>\n</ul>\n<ul>\n <li>Core&nbsp;Sales decline of (11)%, primarily due to the impact of fleet optimization</li>\n</ul>\n<ul>\n <li>Gross Margin of 30.3% and Adjusted2 Gross Margin of 34.0%</li>\n</ul>\n<ul>\n <li>Adjusted&nbsp;Gross Margin reflects 170 bps of higher merchandise margin versus last year, that was more than offset by freight cost increases of 360 bps and which were greater than anticipated, particularly at the end of the quarter</li>\n</ul>\n<ul>\n <li>SG&amp;A expense in-line with expectations</li>\n</ul>\n<ul>\n <li>Adjusted&nbsp;EBITDA of $85 million as a result of Net Sales and Adjusted2 Gross Margin performance</li>\n</ul>\n<ul>\n <li>Guidance outlook for 2021 third quarter established</li>\n</ul>\n<ul>\n <li>Revised full fiscal year 2021 guidance outlook to reflect year-to-date performance</li>\n</ul>\n<p>Mark Tritton, Bed Bath &amp; Beyond’s President and CEO said, “While our results this quarter were below expectations, we remain confident in our multi-year transformation. Following solid growth in June, we saw unexpected, external disruptive forces towards the end of the quarter that impacted our outcome. In August, the final and largest month of our second fiscal period, traffic slowed significantly and, therefore, sales did not materialize as we had anticipated. As COVID-19 fears re-emerged amid the on-going Delta variant, we experienced a challenging environment. This was particularly evident in large, key states such as Florida, Texas and California, which represent a substantial portion of our sales. Furthermore, unprecedented supply chain challenges have been impacting the industry pervasively, and we saw steeper cost inflation escalating by month, especially later in the quarter, beyond the significant increases that we had already anticipated. This outpaced our plans to offset these headwinds. These factors impacted sales and gross margin.\"</p>\n<p>Tritton added, \"Encouragingly, we've continued to make progress against the fundamentals of our three-year transformation strategy. Our buybuy BABY banner continued to build on its positive momentum from the past several quarters, growing double digits due to strength in apparel and travel gear and increasing market share for the period. We also celebrated the July re-opening of our Bed Bath &amp; Beyond banner's NYC flagship store in Chelsea as part of our comprehensive store remodel program, which is exceeding our expectations. Our higher margin Owned Brands are outperforming our penetration goals across the overall chain, and even stronger in remodeled stores. As a group, we continued to leverage our enhanced digital channel, with significant growth above 2019 at nearly double the proportion of sales. Operationally, we entered the next phase of our supply chain modernization through our partnership with Ryder which is instrumental to our strategy. We are committed to executing over the short, mid and long term, especially during these early stages of our multi-year plan.\"</p>\n<p>\"Our financial foundation is strong. We generated positive operating cash flow during the quarter. Our cash balance, coupled with our recently amended asset-based revolving credit facility, provides us on-going capital and liquidity strength of $2.0 billion. We are well positioned to continue our planned investments in our business and pave the way towards a more profitable future. We have the plan, the team and the resources to unlock our potential.\"</p>\n<p><b>Fiscal 2021 Third Quarter Outlook</b></p>\n<p>The Company expects fiscal 2021 third quarter Net Sales of between $1.96 billion to $2.0 billion, which only reflects sales from the Company's Core&nbsp;businesses. Net Sales also includes planned sales reductions from divestitures and the Company's store fleet optimization program. On a Comparable Sales basis, the Company expects to be approximately flat compared to the prior year period.</p>\n<p>The Company expects to achieve Adjusted Gross Margin in the range of 34% to 35%. This guidance reflects the impact of anticipated greater global supply chain challenges</p>\n<p>The Company expects Adjusted&nbsp;EBITDA between $80 million to $85 million and Adjusted2 EPS in the range of $0.00 to $0.05 per diluted share for the fiscal 2021 third quarter.</p>\n<p><b>Fiscal Year 2021 Outlook</b></p>\n<p>Based on its year-to-date performance in the fiscal first half of the year, as well as current expectations for the fiscal third quarter, the Company is revising its fiscal year 2021 guidance outlook.</p>\n<p>The Company now expects higher fiscal year 2021 Net Sales of $8.1 billion to $8.3 billion. The Company expects comparable sales of flat to up slightly for the second through fourth quarters of fiscal 2021.</p>\n<p>Adjusted Gross Margin is now anticipated to be in a range of 34.0% to 35.0% and Adjusted SG&amp;A is expected to be approximately 32%.</p>\n<p>The Company now expects Adjusted EBITDA to be in the range of $425 million to $465 million and Adjusted EPS range of $0.70 to $1.10 per diluted share.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BBBY":"3B家居"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185816399","content_text":"Bed Bath & Beyond stock plunged 13.4% in premarket trading after profit and sales miss, weak guidance.\n\nBed Bath & Beyond Inc. today reported financial results for the second quarter of fiscal 2021 ended August 28, 2021.\n\nQ2 Highlights\n\nComparable Sales decline of (1)% versus Q2 2020 primarily driven by slower than expected traffic trends in August across stores and digital\n\n\nBed Bath & Beyond banner Comparable Sales decline of (4)%; buybuy BABY banner growth of high-teens percentage\n\n\nCore Sales decline of (11)%, primarily due to the impact of fleet optimization\n\n\nGross Margin of 30.3% and Adjusted2 Gross Margin of 34.0%\n\n\nAdjusted Gross Margin reflects 170 bps of higher merchandise margin versus last year, that was more than offset by freight cost increases of 360 bps and which were greater than anticipated, particularly at the end of the quarter\n\n\nSG&A expense in-line with expectations\n\n\nAdjusted EBITDA of $85 million as a result of Net Sales and Adjusted2 Gross Margin performance\n\n\nGuidance outlook for 2021 third quarter established\n\n\nRevised full fiscal year 2021 guidance outlook to reflect year-to-date performance\n\nMark Tritton, Bed Bath & Beyond’s President and CEO said, “While our results this quarter were below expectations, we remain confident in our multi-year transformation. Following solid growth in June, we saw unexpected, external disruptive forces towards the end of the quarter that impacted our outcome. In August, the final and largest month of our second fiscal period, traffic slowed significantly and, therefore, sales did not materialize as we had anticipated. As COVID-19 fears re-emerged amid the on-going Delta variant, we experienced a challenging environment. This was particularly evident in large, key states such as Florida, Texas and California, which represent a substantial portion of our sales. Furthermore, unprecedented supply chain challenges have been impacting the industry pervasively, and we saw steeper cost inflation escalating by month, especially later in the quarter, beyond the significant increases that we had already anticipated. This outpaced our plans to offset these headwinds. These factors impacted sales and gross margin.\"\nTritton added, \"Encouragingly, we've continued to make progress against the fundamentals of our three-year transformation strategy. Our buybuy BABY banner continued to build on its positive momentum from the past several quarters, growing double digits due to strength in apparel and travel gear and increasing market share for the period. We also celebrated the July re-opening of our Bed Bath & Beyond banner's NYC flagship store in Chelsea as part of our comprehensive store remodel program, which is exceeding our expectations. Our higher margin Owned Brands are outperforming our penetration goals across the overall chain, and even stronger in remodeled stores. As a group, we continued to leverage our enhanced digital channel, with significant growth above 2019 at nearly double the proportion of sales. Operationally, we entered the next phase of our supply chain modernization through our partnership with Ryder which is instrumental to our strategy. We are committed to executing over the short, mid and long term, especially during these early stages of our multi-year plan.\"\n\"Our financial foundation is strong. We generated positive operating cash flow during the quarter. Our cash balance, coupled with our recently amended asset-based revolving credit facility, provides us on-going capital and liquidity strength of $2.0 billion. We are well positioned to continue our planned investments in our business and pave the way towards a more profitable future. We have the plan, the team and the resources to unlock our potential.\"\nFiscal 2021 Third Quarter Outlook\nThe Company expects fiscal 2021 third quarter Net Sales of between $1.96 billion to $2.0 billion, which only reflects sales from the Company's Core businesses. Net Sales also includes planned sales reductions from divestitures and the Company's store fleet optimization program. On a Comparable Sales basis, the Company expects to be approximately flat compared to the prior year period.\nThe Company expects to achieve Adjusted Gross Margin in the range of 34% to 35%. This guidance reflects the impact of anticipated greater global supply chain challenges\nThe Company expects Adjusted EBITDA between $80 million to $85 million and Adjusted2 EPS in the range of $0.00 to $0.05 per diluted share for the fiscal 2021 third quarter.\nFiscal Year 2021 Outlook\nBased on its year-to-date performance in the fiscal first half of the year, as well as current expectations for the fiscal third quarter, the Company is revising its fiscal year 2021 guidance outlook.\nThe Company now expects higher fiscal year 2021 Net Sales of $8.1 billion to $8.3 billion. The Company expects comparable sales of flat to up slightly for the second through fourth quarters of fiscal 2021.\nAdjusted Gross Margin is now anticipated to be in a range of 34.0% to 35.0% and Adjusted SG&A is expected to be approximately 32%.\nThe Company now expects Adjusted EBITDA to be in the range of $425 million to $465 million and Adjusted EPS range of $0.70 to $1.10 per diluted share.","news_type":1},"isVote":1,"tweetType":1,"viewCount":428,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866880378,"gmtCreate":1632752985994,"gmtModify":1632798079569,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>$1","listText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>$1","text":"$Naked Brand(NAKD)$$1","images":[{"img":"https://static.tigerbbs.com/057d1fb004ff1ed6e685d532b1ffbd2e","width":"1080","height":"3075"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":1,"link":"https://laohu8.com/post/866880378","isVote":1,"tweetType":1,"viewCount":512,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":861145738,"gmtCreate":1632475284324,"gmtModify":1632720286972,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like and commnet","listText":"Like and commnet","text":"Like and commnet","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/861145738","repostId":"1199759162","repostType":4,"repost":{"id":"1199759162","pubTimestamp":1632454663,"share":"https://www.laohu8.com/m/news/1199759162?lang=&edition=full","pubTime":"2021-09-24 11:37","market":"us","language":"en","title":"If Bitcoin Really Is Digital Gold, Then $500,000 Is the Next Stop","url":"https://stock-news.laohu8.com/highlight/detail?id=1199759162","media":"investorplace","summary":"Everyone loves to throw out long-term price targets on Bitcoin.\nARK Invest fund manager Cathie Wood ","content":"<p>Everyone loves to throw out long-term price targets on&nbsp;<b><u>Bitcoin</u></b>.</p>\n<p>ARK Invest fund manager&nbsp;<b>Cathie Wood</b>&nbsp;last week reiterated her firm’s call for Bitcoin to trend toward $500,000 per coin over the next several years.&nbsp;<b>Tyler Winklevoss</b>&nbsp;of Facebook fame and big crypto enthusiast has also pounded on the table about a $500,000 long-term price target for Bitcoin.</p>\n<p>Meanwhile, the relatively conservative analyst team over at&nbsp;<b>JPMorgan</b>&nbsp;has set a theoretical long-term price target for BTC of $130,000. A leaked&nbsp;<b>Citibank</b>&nbsp;report shows that the analysts over there think that the price could climb toward $300,000. Billionaire&nbsp;<b>Tim Draper</b>&nbsp;has gone on record multiple times saying Bitcoin prices will eclipse $250,000 by the end of 2022.</p>\n<p>And, in the most bullish call of them all,&nbsp;<b>Anthony Pompliano</b>– co-founder and partner at Morgan Creek Digital Assets – has said Bitcoin prices could soar to $1 million per token in the long run.</p>\n<p>Big numbers. Yes. But can Bitcoin really soar toward $200,000? $300,000? Even $500,000 or higher in the long run?</p>\n<p>Our short answer:<b><i>Yes.</i></b></p>\n<p>And the reasoning is pretty simple. Bitcoin is the digital version of gold. The gold market is an $11 trillion market. If Bitcoin gets that big, you’re talking an $11 trillion market on 21 million tokens, which implies a price per token of about $500,000.</p>\n<p>That’s the back-of-the-envelope reasoning and math behind the $500,000 price target.</p>\n<p>Of course, that model rests on some major assumptions. One, Bitcoin is the digital version of gold, and two, the Bitcoin market will be as big as the gold market.</p>\n<p><u>We think both are fair assumptions</u>.</p>\n<p>The modern value of gold derives from&nbsp;<b><i>scarcity</i></b>. Sure, maybe once upon a time, gold was used to barter for goods or used to make swords and shields. Not too long ago, it was used in some semiconductor chips.</p>\n<p>But those days are gone. Today, gold is used for nothing. Its value is in the fact that it has finite supply and, therefore, is a good store of value.</p>\n<p>The same is true for Bitcoin. In fact, it’s even more true for Bitcoin. There are, by definition, only 21 million Bitcoins in the world. There will never be more than that. Meanwhile, in the gold market, more gold mining efforts can always be put online to increase supply as demand increases.</p>\n<p>In other words, Bitcoin has more scarcity than gold and, therefore, isn’t just the digital version of gold – it is a digital and superior version of gold.</p>\n<p>Meanwhile, Bitcoin is&nbsp;<b><i>digital</i></b>, while gold is&nbsp;<b><i>physical</i></b>, and the whole world is pivoting toward digitization these days. Media is digital. Shopping is digital. Entertainment is digital. Communications are digital. Work is digital. Health is digital. Everything is digital.</p>\n<p>In that world, money will inevitably become digital, too. Indeed, that’s already happening. Venmo. Cash App. PayPal. SoFi. All of these digital money apps are soaring in usage right now, while the volume of cash transactions is plummeting.</p>\n<p>Therefore, Bitcoin is gold made for the modern world. You can’t send gold through a social media platform, or a streaming service, or use it buy a good online.&nbsp;<b>But you can use Bitcoin for that.</b></p>\n<p>To that extent, it’s easy to see why folks will ditch their physical store of value (gold) for a digital store of value (Bitcoin) – and why the Bitcoin market will become as big as (if not bigger than) the gold market.</p>\n<p>All in all, we think the fundamental reasoning underlying the Bitcoin market supports that Bitcoin prices will trend towards $500,000 in the long run.</p>\n<p>How long will it take to get there? No one really knows. Our best guess is about 10 years – and if so, you’re talking about an asset that will increase 10X in value in 10 years.</p>\n<p><u>That’s an</u>&nbsp;<u><b><i>amazing</i></b></u>&nbsp;<u>return</u>.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>If Bitcoin Really Is Digital Gold, Then $500,000 Is the Next Stop</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIf Bitcoin Really Is Digital Gold, Then $500,000 Is the Next Stop\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-24 11:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/hypergrowthinvesting/2021/09/if-bitcoin-really-is-digital-gold-then-500000-is-the-next-stop/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Everyone loves to throw out long-term price targets on Bitcoin.\nARK Invest fund manager Cathie Wood last week reiterated her firm’s call for Bitcoin to trend toward $500,000 per coin over the next ...</p>\n\n<a href=\"https://investorplace.com/hypergrowthinvesting/2021/09/if-bitcoin-really-is-digital-gold-then-500000-is-the-next-stop/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COIN":"Coinbase Global, Inc."},"source_url":"https://investorplace.com/hypergrowthinvesting/2021/09/if-bitcoin-really-is-digital-gold-then-500000-is-the-next-stop/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199759162","content_text":"Everyone loves to throw out long-term price targets on Bitcoin.\nARK Invest fund manager Cathie Wood last week reiterated her firm’s call for Bitcoin to trend toward $500,000 per coin over the next several years. Tyler Winklevoss of Facebook fame and big crypto enthusiast has also pounded on the table about a $500,000 long-term price target for Bitcoin.\nMeanwhile, the relatively conservative analyst team over at JPMorgan has set a theoretical long-term price target for BTC of $130,000. A leaked Citibank report shows that the analysts over there think that the price could climb toward $300,000. Billionaire Tim Draper has gone on record multiple times saying Bitcoin prices will eclipse $250,000 by the end of 2022.\nAnd, in the most bullish call of them all, Anthony Pompliano– co-founder and partner at Morgan Creek Digital Assets – has said Bitcoin prices could soar to $1 million per token in the long run.\nBig numbers. Yes. But can Bitcoin really soar toward $200,000? $300,000? Even $500,000 or higher in the long run?\nOur short answer:Yes.\nAnd the reasoning is pretty simple. Bitcoin is the digital version of gold. The gold market is an $11 trillion market. If Bitcoin gets that big, you’re talking an $11 trillion market on 21 million tokens, which implies a price per token of about $500,000.\nThat’s the back-of-the-envelope reasoning and math behind the $500,000 price target.\nOf course, that model rests on some major assumptions. One, Bitcoin is the digital version of gold, and two, the Bitcoin market will be as big as the gold market.\nWe think both are fair assumptions.\nThe modern value of gold derives from scarcity. Sure, maybe once upon a time, gold was used to barter for goods or used to make swords and shields. Not too long ago, it was used in some semiconductor chips.\nBut those days are gone. Today, gold is used for nothing. Its value is in the fact that it has finite supply and, therefore, is a good store of value.\nThe same is true for Bitcoin. In fact, it’s even more true for Bitcoin. There are, by definition, only 21 million Bitcoins in the world. There will never be more than that. Meanwhile, in the gold market, more gold mining efforts can always be put online to increase supply as demand increases.\nIn other words, Bitcoin has more scarcity than gold and, therefore, isn’t just the digital version of gold – it is a digital and superior version of gold.\nMeanwhile, Bitcoin is digital, while gold is physical, and the whole world is pivoting toward digitization these days. Media is digital. Shopping is digital. Entertainment is digital. Communications are digital. Work is digital. Health is digital. Everything is digital.\nIn that world, money will inevitably become digital, too. Indeed, that’s already happening. Venmo. Cash App. PayPal. SoFi. All of these digital money apps are soaring in usage right now, while the volume of cash transactions is plummeting.\nTherefore, Bitcoin is gold made for the modern world. You can’t send gold through a social media platform, or a streaming service, or use it buy a good online. But you can use Bitcoin for that.\nTo that extent, it’s easy to see why folks will ditch their physical store of value (gold) for a digital store of value (Bitcoin) – and why the Bitcoin market will become as big as (if not bigger than) the gold market.\nAll in all, we think the fundamental reasoning underlying the Bitcoin market supports that Bitcoin prices will trend towards $500,000 in the long run.\nHow long will it take to get there? No one really knows. Our best guess is about 10 years – and if so, you’re talking about an asset that will increase 10X in value in 10 years.\nThat’s an amazing return.","news_type":1},"isVote":1,"tweetType":1,"viewCount":178,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864704246,"gmtCreate":1633144661009,"gmtModify":1633144661758,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like and comment&nbsp;","listText":"Like and comment&nbsp;","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/864704246","repostId":"2172969568","repostType":4,"repost":{"id":"2172969568","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1633123800,"share":"https://www.laohu8.com/m/news/2172969568?lang=&edition=full","pubTime":"2021-10-02 05:30","market":"hk","language":"en","title":"Wells Fargo & Co. Stock Rises Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2172969568","media":"Dow Jones","summary":"Shares of Wells Fargo & Co. $(WFC)$ advanced 1.31% to $47.02 Friday, on what proved to be an all-aro","content":"<p>Shares of Wells Fargo &amp; Co. <a href=\"https://laohu8.com/S/WFC\">$(WFC)$</a> advanced 1.31% to $47.02 Friday, on what proved to be an all-around great trading session for the stock market, with the S&amp;P 500 Index rising 1.15% to 4,357.04 and the Dow Jones Industrial Average rising 1.43% to 34,326.46. Wells Fargo &amp; Co. closed $4.39 short of its 52-week high ($51.41), which the company reached on August 13th.</p>\n<p>The stock underperformed when compared to some of its competitors Friday, as JPMorgan Chase &amp; Co. <a href=\"https://laohu8.com/S/JPM\">$(JPM)$</a> rose 2.10% to $167.13, $Bank of America Corp(BAC-N)$. <a href=\"https://laohu8.com/S/BAC\">$(BAC)$</a> rose 1.48% to $43.08, and $Citigroup Inc(C-N)$. <a href=\"https://laohu8.com/S/C\">$(C)$</a> rose 1.42% to $71.18. Trading volume (18.0 M) remained 8.8 million below its 50-day average volume of 26.8 M.</p>\n<p>Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2021.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wells Fargo & Co. Stock Rises Friday, Outperforms Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWells Fargo & Co. Stock Rises Friday, Outperforms Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-10-02 05:30</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Wells Fargo &amp; Co. <a href=\"https://laohu8.com/S/WFC\">$(WFC)$</a> advanced 1.31% to $47.02 Friday, on what proved to be an all-around great trading session for the stock market, with the S&amp;P 500 Index rising 1.15% to 4,357.04 and the Dow Jones Industrial Average rising 1.43% to 34,326.46. Wells Fargo &amp; Co. closed $4.39 short of its 52-week high ($51.41), which the company reached on August 13th.</p>\n<p>The stock underperformed when compared to some of its competitors Friday, as JPMorgan Chase &amp; Co. <a href=\"https://laohu8.com/S/JPM\">$(JPM)$</a> rose 2.10% to $167.13, $Bank of America Corp(BAC-N)$. <a href=\"https://laohu8.com/S/BAC\">$(BAC)$</a> rose 1.48% to $43.08, and $Citigroup Inc(C-N)$. <a href=\"https://laohu8.com/S/C\">$(C)$</a> rose 1.42% to $71.18. Trading volume (18.0 M) remained 8.8 million below its 50-day average volume of 26.8 M.</p>\n<p>Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2021.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WFC":"富国银行"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172969568","content_text":"Shares of Wells Fargo & Co. $(WFC)$ advanced 1.31% to $47.02 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.15% to 4,357.04 and the Dow Jones Industrial Average rising 1.43% to 34,326.46. Wells Fargo & Co. closed $4.39 short of its 52-week high ($51.41), which the company reached on August 13th.\nThe stock underperformed when compared to some of its competitors Friday, as JPMorgan Chase & Co. $(JPM)$ rose 2.10% to $167.13, $Bank of America Corp(BAC-N)$. $(BAC)$ rose 1.48% to $43.08, and $Citigroup Inc(C-N)$. $(C)$ rose 1.42% to $71.18. Trading volume (18.0 M) remained 8.8 million below its 50-day average volume of 26.8 M.\nData source: Dow Jones Market Data, FactSet. Data compiled October 1, 2021.","news_type":1},"isVote":1,"tweetType":1,"viewCount":311,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864704819,"gmtCreate":1633144640166,"gmtModify":1633144640925,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/864704819","repostId":"2172969568","repostType":4,"repost":{"id":"2172969568","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1633123800,"share":"https://www.laohu8.com/m/news/2172969568?lang=&edition=full","pubTime":"2021-10-02 05:30","market":"hk","language":"en","title":"Wells Fargo & Co. Stock Rises Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2172969568","media":"Dow Jones","summary":"Shares of Wells Fargo & Co. $(WFC)$ advanced 1.31% to $47.02 Friday, on what proved to be an all-aro","content":"<p>Shares of Wells Fargo &amp; Co. <a href=\"https://laohu8.com/S/WFC\">$(WFC)$</a> advanced 1.31% to $47.02 Friday, on what proved to be an all-around great trading session for the stock market, with the S&amp;P 500 Index rising 1.15% to 4,357.04 and the Dow Jones Industrial Average rising 1.43% to 34,326.46. Wells Fargo &amp; Co. closed $4.39 short of its 52-week high ($51.41), which the company reached on August 13th.</p>\n<p>The stock underperformed when compared to some of its competitors Friday, as JPMorgan Chase &amp; Co. <a href=\"https://laohu8.com/S/JPM\">$(JPM)$</a> rose 2.10% to $167.13, $Bank of America Corp(BAC-N)$. <a href=\"https://laohu8.com/S/BAC\">$(BAC)$</a> rose 1.48% to $43.08, and $Citigroup Inc(C-N)$. <a href=\"https://laohu8.com/S/C\">$(C)$</a> rose 1.42% to $71.18. Trading volume (18.0 M) remained 8.8 million below its 50-day average volume of 26.8 M.</p>\n<p>Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2021.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wells Fargo & Co. Stock Rises Friday, Outperforms Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWells Fargo & Co. Stock Rises Friday, Outperforms Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-10-02 05:30</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Wells Fargo &amp; Co. <a href=\"https://laohu8.com/S/WFC\">$(WFC)$</a> advanced 1.31% to $47.02 Friday, on what proved to be an all-around great trading session for the stock market, with the S&amp;P 500 Index rising 1.15% to 4,357.04 and the Dow Jones Industrial Average rising 1.43% to 34,326.46. Wells Fargo &amp; Co. closed $4.39 short of its 52-week high ($51.41), which the company reached on August 13th.</p>\n<p>The stock underperformed when compared to some of its competitors Friday, as JPMorgan Chase &amp; Co. <a href=\"https://laohu8.com/S/JPM\">$(JPM)$</a> rose 2.10% to $167.13, $Bank of America Corp(BAC-N)$. <a href=\"https://laohu8.com/S/BAC\">$(BAC)$</a> rose 1.48% to $43.08, and $Citigroup Inc(C-N)$. <a href=\"https://laohu8.com/S/C\">$(C)$</a> rose 1.42% to $71.18. Trading volume (18.0 M) remained 8.8 million below its 50-day average volume of 26.8 M.</p>\n<p>Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2021.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WFC":"富国银行"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172969568","content_text":"Shares of Wells Fargo & Co. $(WFC)$ advanced 1.31% to $47.02 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.15% to 4,357.04 and the Dow Jones Industrial Average rising 1.43% to 34,326.46. Wells Fargo & Co. closed $4.39 short of its 52-week high ($51.41), which the company reached on August 13th.\nThe stock underperformed when compared to some of its competitors Friday, as JPMorgan Chase & Co. $(JPM)$ rose 2.10% to $167.13, $Bank of America Corp(BAC-N)$. $(BAC)$ rose 1.48% to $43.08, and $Citigroup Inc(C-N)$. $(C)$ rose 1.42% to $71.18. Trading volume (18.0 M) remained 8.8 million below its 50-day average volume of 26.8 M.\nData source: Dow Jones Market Data, FactSet. Data compiled October 1, 2021.","news_type":1},"isVote":1,"tweetType":1,"viewCount":792,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864704948,"gmtCreate":1633144611026,"gmtModify":1633144611840,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>gogogo","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>gogogo","text":"$Palantir Technologies Inc.(PLTR)$gogogo","images":[{"img":"https://static.tigerbbs.com/0bc656080ec822fccf7491af16964d53","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864704948","isVote":1,"tweetType":1,"viewCount":633,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":868330238,"gmtCreate":1632591100224,"gmtModify":1632654413335,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>yes","listText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>yes","text":"$Cerebain Biotech Corp.(CBBT)$yes","images":[{"img":"https://static.tigerbbs.com/cbb0e122e1ccd81847d75df07dda9431","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/868330238","isVote":1,"tweetType":1,"viewCount":169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":603806655,"gmtCreate":1638388806283,"gmtModify":1638388807079,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PRPO\">$Precipio, Inc.(PRPO)$</a>Rebound will come!","listText":"<a href=\"https://laohu8.com/S/PRPO\">$Precipio, Inc.(PRPO)$</a>Rebound will come!","text":"$Precipio, Inc.(PRPO)$Rebound will come!","images":[{"img":"https://static.tigerbbs.com/ef3e2f133c59107eb0b3191ab6335623","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603806655","isVote":1,"tweetType":1,"viewCount":631,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":820363428,"gmtCreate":1633354412369,"gmtModify":1633354474632,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>dammm","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>dammm","text":"$Palantir Technologies Inc.(PLTR)$dammm","images":[{"img":"https://static.tigerbbs.com/2f80ab815eb8dc567b6b02b30422b1f2","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820363428","isVote":1,"tweetType":1,"viewCount":664,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":865006108,"gmtCreate":1632921673480,"gmtModify":1632921674272,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>buy when low","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>buy when low","text":"$Alibaba(BABA)$buy when low","images":[{"img":"https://static.tigerbbs.com/224b71698fc48d38343d2dbb2f229eed","width":"1080","height":"3355"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/865006108","isVote":1,"tweetType":1,"viewCount":279,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":868561276,"gmtCreate":1632673193295,"gmtModify":1632798649807,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>yess","listText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>yess","text":"$Cerebain Biotech Corp.(CBBT)$yess","images":[{"img":"https://static.tigerbbs.com/cbb0e122e1ccd81847d75df07dda9431","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/868561276","isVote":1,"tweetType":1,"viewCount":221,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":868561888,"gmtCreate":1632673167244,"gmtModify":1632798650049,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>whoooooooop","listText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>whoooooooop","text":"$Naked Brand(NAKD)$whoooooooop","images":[{"img":"https://static.tigerbbs.com/793ab7775ff50a91f352d98bdb4ac4ef","width":"1080","height":"3162"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/868561888","isVote":1,"tweetType":1,"viewCount":256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":865529303,"gmtCreate":1633003714272,"gmtModify":1633003715062,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"All in","listText":"All in","text":"All in","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865529303","repostId":"2171937752","repostType":4,"repost":{"id":"2171937752","pubTimestamp":1633002256,"share":"https://www.laohu8.com/m/news/2171937752?lang=&edition=full","pubTime":"2021-09-30 19:44","market":"us","language":"en","title":"4 Stocks Expected to Increase Sales 25,750% to 2,970,000% in 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2171937752","media":"Motley Fool","summary":"These companies could deliver jaw-dropping revenue growth through mid-decade.","content":"<p>High-growth stocks have dominated Wall Street for more than a decade -- and with good reason. Historically low lending rates and an accommodative monetary policy have paved the way for fast-paced companies to borrow at attractive rates.</p>\n<p>But for some companies, sales growth is about to kick into high gear. When you're building a business from the ground up, going from practically nothing in sales to hundreds of millions or billions of dollars in revenue in just a couple of years can be a jaw-dropping experience.</p>\n<p>The following four companies are expected to do just that. According to Wall Street's consensus estimates, these four stocks are forecast to increase sales by 25,750% to as much as 2,970,000% (that's nearly 3 million percent) over the next five years.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ee55796575e48ba3143c099af095e386\" tg-width=\"700\" tg-height=\"535\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Vaxart: 25,752% implied sales growth by 2025</h2>\n<p>A clinical-stage biotech stock angling for its first approved therapy is a perfect example of a business that could grow from a relatively small amount of non-recurring revenue to a considerably larger sum of recurring sales. Drug-developer <b>Vaxart</b> (NASDAQ:VXRT) is expected to increase its annual sales from the $4.05 million reported in 2020 to a consensus estimate of $1.047 billion by mid-decade. That's an increase of about 25,750%, if Wall Street's numbers prove accurate.</p>\n<p>Vaxart's future is pinned to the success of its VAAST platform. \"VAAST\" stands for Vector-Adjuvant-Antigen Standardized Technology and encompasses the company's attempts to develop proprietary oral vaccines. Whereas standard vaccines administered in a shot can activate systemic immunity, oral-vaccine tablets would be designed to activate systemic and mucosal immunity in the intestines, lungs, nose, and mouth. In other words, this dual-action approach could carry better immunity against potentially deadly viruses.</p>\n<p>The oral vaccine that's arguably received the most attention for Vaxart is VXA-CoV2-1, an early-stage tablet designed to combat the coronavirus disease 2019 (COVID-19). In May, Vaxart announced that its phase 1 study of VXA-CoV2-1 led to clear immune response in participants, although high levels of neutralizing antibodies weren't present. Traditional shot-in-the-arm vaccines have led to high levels of neutralizing antibodies in clinical trials.</p>\n<p>But Vaxart's work isn't close to being finished. In early August, it received the go-ahead from the U.S. Food and Drug Administration (FDA) to commence an oral-tablet study for a very specific protein to combat COVID-19. It could be some time before investors know if oral vaccines are a viable solution, but the convenience factor certainly makes this trial worth watching.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/650d01a926fded89c361069c76a528f5\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>CRISPR Technologies: 191,416% implied sales growth by 2025</h2>\n<p>Did I mention that clinical-stage biotech stocks are a great source of jaw-dropping growth over the next decade? <b>CRISPR Therapeutics</b> (NASDAQ:CRSP), a company leaning on gene-editing technology to precisely alter genomic DNA and tackle hard-to-treat diseases, is expected to see sales climb from $719,000 in 2020 to a consensus of $1.377 billion by 2025. That's an improvement of more than 191,000% in five years.</p>\n<p>Arguably the biggest positive for CRISPR is that it's working with <b>Vertex Pharmaceuticals</b> (NASDAQ:VRTX) in the development of CTX001 for the treatment of transfusion-dependent beta thalassemia (TDT) and sickle cell disease (SCD). Vertex has a storied history of developing novel therapies for hard-to-treat illnesses, such as cystic fibrosis.</p>\n<p>It also doesn't hurt that Vertex's deep pockets are helping to lift CRISPR's bank account. Following a $900 million collaboration payment in the second quarter, CRISPR was sitting on nearly $2.6 billion in cash, cash equivalents, and marketable securities. That's plenty of capital to fund its ongoing clinical studies.</p>\n<p>Initial trial data for CTX001 has also been encouraging. At the European Hematology Association's annual meeting in June, the company announced that all 15 patients with TDT were transfusion-free after follow-ups of at least three months. TDT patients can require weekly transfusions, depending on the severity of their illnesses. Management believes regulatory filings, assuming all goes well in clinical studies, could come by or before mid-2023.</p>\n<p>While CRISPR Technologies is far from the only company looking to tackle TDT and SCD, it's among the best funded and has Vertex in its corner. That gives it a better-than-average chance of success, at least in my book.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a38605bee8e62f3e8aa414fa24278e7e\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Ocugen: 604,551% implied sales growth by 2025</h2>\n<p>Yet another clinical-stage biotech company expected to see sales go from virtually zero to a big number with a lot of zeroes is <b>Ocugen</b> (NASDAQ:OCGN). After the company reported $43,000 in sales last year, Wall Street's consensus has it generating $260 million in full-year sales by 2025. We're talking about a nearly 605,000% sales increase in five years.</p>\n<p>Not to sound like a broken record, but a COVID-19 vaccine is Ocugen's potential catalyst. The company has partnered with India's Bharat Biotech for the commercialization of Covaxin. A phase 3 trial of 25,800 adults aged 18 and up in India demonstrated a vaccine efficacy of 77.8% for symptomatic infections, 63.6% against asymptomatic infections, and most importantly was 93.4% effective against severe COVID-19 disease. The July-reported data from Bharat also showed a 65.2% efficacy against the delta variant.</p>\n<p>With so many people left to be vaccinated, this probably sounds like a slam-dunk for some form of emergency authorization use in developed or emerging markets. However, there's a big problem for Ocugen: It only has co-commercialization rights for Covaxin in the U.S. and Canada. The U.S. has ordered more-than-enough vaccines to inoculate all eligible Americans, and likely has doses in reserve should booster shots become necessary. The same could be said for Canada, which invested heavily in vaccine purchases.</p>\n<p>While there's no such thing as having too many vaccine options during a pandemic, Covaxin's initial efficacy doesn't pop quite like the vaccines from <b>Moderna</b>, <b>Pfizer</b>/<b>BioNTech</b>, or even <b>Novavax</b>, which looks to be nearing its own emergency use authorization in the United States. Suffice it to say, Ocugen's sales forecast may prove unattainable.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/deae33b8912cffd8d0ba896164abff66\" tg-width=\"700\" tg-height=\"378\" width=\"100%\" height=\"auto\"><span>A rendering of the all-electric Nikola Tre semi. Image source: Nikola.</span></p>\n<h2>Nikola: 2,970,426% implied sales growth by 2025</h2>\n<p>However, the crème de la crème of growth opportunities, at least pertaining to this list, is electric vehicle (EV) manufacturer <b>Nikola</b> (NASDAQ:NKLA). The expectation is that we'll see Nikola's sales catapult from a reported $95,000 in 2020 to a consensus of $2.822 billion by 2025. This equates to almost a 3 million percent jump in annual revenue.</p>\n<p>The growth opportunity for EVs is pretty straightforward. With developed countries like the U.S. tackling climate change head-on, replacing fossil-fuel-burning vehicles with alternative-energy vehicles is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the easiest ways to make a difference. It's going to take decades for consumers and businesses to make this shift, which leaves plenty of room for multiple EV manufacturers to thrive.</p>\n<p>The issue for Nikola is that it's dealing with a public relations mess. Last year, short-side firm Hindenburg Research released a report that alleged Nikola was a fraud. Even though an independent review found that many of Hindenburg's allegations weren't true, it was discovered that founder Trevor Milton's statements regarding pre-sells weren't accurate.</p>\n<p>Despite stepping down last year, Milton was indicted by the U.S. Department of Justice on three charges of misleading investors. Ultimately, Nikola will have to overcome a breach of trust to sell its vehicles, and it likely will need a lot more cash than it has now to build up its production. Personally, I'm skeptical the company will reach this lofty sales consensus by mid-decade.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Stocks Expected to Increase Sales 25,750% to 2,970,000% in 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Stocks Expected to Increase Sales 25,750% to 2,970,000% in 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-30 19:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/30/4-stocks-increase-sales-25750-to-2970000-5-years/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>High-growth stocks have dominated Wall Street for more than a decade -- and with good reason. Historically low lending rates and an accommodative monetary policy have paved the way for fast-paced ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/30/4-stocks-increase-sales-25750-to-2970000-5-years/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NKLA":"Nikola Corporation","VXRT":"Vaxart, Inc","CRSP":"CRISPR Therapeutics AG","OCGN":"Ocugen"},"source_url":"https://www.fool.com/investing/2021/09/30/4-stocks-increase-sales-25750-to-2970000-5-years/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2171937752","content_text":"High-growth stocks have dominated Wall Street for more than a decade -- and with good reason. Historically low lending rates and an accommodative monetary policy have paved the way for fast-paced companies to borrow at attractive rates.\nBut for some companies, sales growth is about to kick into high gear. When you're building a business from the ground up, going from practically nothing in sales to hundreds of millions or billions of dollars in revenue in just a couple of years can be a jaw-dropping experience.\nThe following four companies are expected to do just that. According to Wall Street's consensus estimates, these four stocks are forecast to increase sales by 25,750% to as much as 2,970,000% (that's nearly 3 million percent) over the next five years.\nImage source: Getty Images.\nVaxart: 25,752% implied sales growth by 2025\nA clinical-stage biotech stock angling for its first approved therapy is a perfect example of a business that could grow from a relatively small amount of non-recurring revenue to a considerably larger sum of recurring sales. Drug-developer Vaxart (NASDAQ:VXRT) is expected to increase its annual sales from the $4.05 million reported in 2020 to a consensus estimate of $1.047 billion by mid-decade. That's an increase of about 25,750%, if Wall Street's numbers prove accurate.\nVaxart's future is pinned to the success of its VAAST platform. \"VAAST\" stands for Vector-Adjuvant-Antigen Standardized Technology and encompasses the company's attempts to develop proprietary oral vaccines. Whereas standard vaccines administered in a shot can activate systemic immunity, oral-vaccine tablets would be designed to activate systemic and mucosal immunity in the intestines, lungs, nose, and mouth. In other words, this dual-action approach could carry better immunity against potentially deadly viruses.\nThe oral vaccine that's arguably received the most attention for Vaxart is VXA-CoV2-1, an early-stage tablet designed to combat the coronavirus disease 2019 (COVID-19). In May, Vaxart announced that its phase 1 study of VXA-CoV2-1 led to clear immune response in participants, although high levels of neutralizing antibodies weren't present. Traditional shot-in-the-arm vaccines have led to high levels of neutralizing antibodies in clinical trials.\nBut Vaxart's work isn't close to being finished. In early August, it received the go-ahead from the U.S. Food and Drug Administration (FDA) to commence an oral-tablet study for a very specific protein to combat COVID-19. It could be some time before investors know if oral vaccines are a viable solution, but the convenience factor certainly makes this trial worth watching.\nImage source: Getty Images.\nCRISPR Technologies: 191,416% implied sales growth by 2025\nDid I mention that clinical-stage biotech stocks are a great source of jaw-dropping growth over the next decade? CRISPR Therapeutics (NASDAQ:CRSP), a company leaning on gene-editing technology to precisely alter genomic DNA and tackle hard-to-treat diseases, is expected to see sales climb from $719,000 in 2020 to a consensus of $1.377 billion by 2025. That's an improvement of more than 191,000% in five years.\nArguably the biggest positive for CRISPR is that it's working with Vertex Pharmaceuticals (NASDAQ:VRTX) in the development of CTX001 for the treatment of transfusion-dependent beta thalassemia (TDT) and sickle cell disease (SCD). Vertex has a storied history of developing novel therapies for hard-to-treat illnesses, such as cystic fibrosis.\nIt also doesn't hurt that Vertex's deep pockets are helping to lift CRISPR's bank account. Following a $900 million collaboration payment in the second quarter, CRISPR was sitting on nearly $2.6 billion in cash, cash equivalents, and marketable securities. That's plenty of capital to fund its ongoing clinical studies.\nInitial trial data for CTX001 has also been encouraging. At the European Hematology Association's annual meeting in June, the company announced that all 15 patients with TDT were transfusion-free after follow-ups of at least three months. TDT patients can require weekly transfusions, depending on the severity of their illnesses. Management believes regulatory filings, assuming all goes well in clinical studies, could come by or before mid-2023.\nWhile CRISPR Technologies is far from the only company looking to tackle TDT and SCD, it's among the best funded and has Vertex in its corner. That gives it a better-than-average chance of success, at least in my book.\nImage source: Getty Images.\nOcugen: 604,551% implied sales growth by 2025\nYet another clinical-stage biotech company expected to see sales go from virtually zero to a big number with a lot of zeroes is Ocugen (NASDAQ:OCGN). After the company reported $43,000 in sales last year, Wall Street's consensus has it generating $260 million in full-year sales by 2025. We're talking about a nearly 605,000% sales increase in five years.\nNot to sound like a broken record, but a COVID-19 vaccine is Ocugen's potential catalyst. The company has partnered with India's Bharat Biotech for the commercialization of Covaxin. A phase 3 trial of 25,800 adults aged 18 and up in India demonstrated a vaccine efficacy of 77.8% for symptomatic infections, 63.6% against asymptomatic infections, and most importantly was 93.4% effective against severe COVID-19 disease. The July-reported data from Bharat also showed a 65.2% efficacy against the delta variant.\nWith so many people left to be vaccinated, this probably sounds like a slam-dunk for some form of emergency authorization use in developed or emerging markets. However, there's a big problem for Ocugen: It only has co-commercialization rights for Covaxin in the U.S. and Canada. The U.S. has ordered more-than-enough vaccines to inoculate all eligible Americans, and likely has doses in reserve should booster shots become necessary. The same could be said for Canada, which invested heavily in vaccine purchases.\nWhile there's no such thing as having too many vaccine options during a pandemic, Covaxin's initial efficacy doesn't pop quite like the vaccines from Moderna, Pfizer/BioNTech, or even Novavax, which looks to be nearing its own emergency use authorization in the United States. Suffice it to say, Ocugen's sales forecast may prove unattainable.\nA rendering of the all-electric Nikola Tre semi. Image source: Nikola.\nNikola: 2,970,426% implied sales growth by 2025\nHowever, the crème de la crème of growth opportunities, at least pertaining to this list, is electric vehicle (EV) manufacturer Nikola (NASDAQ:NKLA). The expectation is that we'll see Nikola's sales catapult from a reported $95,000 in 2020 to a consensus of $2.822 billion by 2025. This equates to almost a 3 million percent jump in annual revenue.\nThe growth opportunity for EVs is pretty straightforward. With developed countries like the U.S. tackling climate change head-on, replacing fossil-fuel-burning vehicles with alternative-energy vehicles is one of the easiest ways to make a difference. It's going to take decades for consumers and businesses to make this shift, which leaves plenty of room for multiple EV manufacturers to thrive.\nThe issue for Nikola is that it's dealing with a public relations mess. Last year, short-side firm Hindenburg Research released a report that alleged Nikola was a fraud. Even though an independent review found that many of Hindenburg's allegations weren't true, it was discovered that founder Trevor Milton's statements regarding pre-sells weren't accurate.\nDespite stepping down last year, Milton was indicted by the U.S. Department of Justice on three charges of misleading investors. Ultimately, Nikola will have to overcome a breach of trust to sell its vehicles, and it likely will need a lot more cash than it has now to build up its production. Personally, I'm skeptical the company will reach this lofty sales consensus by mid-decade.","news_type":1},"isVote":1,"tweetType":1,"viewCount":282,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865567792,"gmtCreate":1633003648564,"gmtModify":1633003649314,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>well","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>well","text":"$Palantir Technologies Inc.(PLTR)$well","images":[{"img":"https://static.tigerbbs.com/86329bdcba7308c7be27a96b726946f2","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865567792","isVote":1,"tweetType":1,"viewCount":570,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":865008440,"gmtCreate":1632921642056,"gmtModify":1632925025896,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PRPO\">$Precipio, Inc.(PRPO)$</a>zzzzzz","listText":"<a href=\"https://laohu8.com/S/PRPO\">$Precipio, Inc.(PRPO)$</a>zzzzzz","text":"$Precipio, Inc.(PRPO)$zzzzzz","images":[{"img":"https://static.tigerbbs.com/9abfb87b6bdf83a9b5a4574221ff1c78","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865008440","isVote":1,"tweetType":1,"viewCount":256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":862967619,"gmtCreate":1632831069365,"gmtModify":1632831069591,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PRPO\">$Precipio, Inc.(PRPO)$</a>omg","listText":"<a href=\"https://laohu8.com/S/PRPO\">$Precipio, Inc.(PRPO)$</a>omg","text":"$Precipio, Inc.(PRPO)$omg","images":[{"img":"https://static.tigerbbs.com/85931d80a9c701c224ac86e0bc7bcf6b","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/862967619","isVote":1,"tweetType":1,"viewCount":157,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":866817515,"gmtCreate":1632752961937,"gmtModify":1632798080189,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>kkkkk","listText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>kkkkk","text":"$Cerebain Biotech Corp.(CBBT)$kkkkk","images":[{"img":"https://static.tigerbbs.com/cbb0e122e1ccd81847d75df07dda9431","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/866817515","isVote":1,"tweetType":1,"viewCount":239,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":868689394,"gmtCreate":1632639341818,"gmtModify":1632647278336,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>haha","listText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>haha","text":"$Cerebain Biotech Corp.(CBBT)$haha","images":[{"img":"https://static.tigerbbs.com/cbb0e122e1ccd81847d75df07dda9431","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/868689394","isVote":1,"tweetType":1,"viewCount":98,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":868330602,"gmtCreate":1632591090206,"gmtModify":1632654416336,"author":{"id":"3559204036277229","authorId":"3559204036277229","name":"jamjam","avatar":"https://static.tigerbbs.com/6542201483b33e63d9036c1e565275b2","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>yes","listText":"<a href=\"https://laohu8.com/S/CBBT\">$Cerebain Biotech Corp.(CBBT)$</a>yes","text":"$Cerebain Biotech Corp.(CBBT)$yes","images":[{"img":"https://static.tigerbbs.com/d8f51b73b84fd1c3af3c677abfe6ff36","width":"1080","height":"3075"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/868330602","isVote":1,"tweetType":1,"viewCount":223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"lives":[]}